WO2006123784A1 - Anti-bacterial composition and anti-bacterial material - Google Patents

Anti-bacterial composition and anti-bacterial material Download PDF

Info

Publication number
WO2006123784A1
WO2006123784A1 PCT/JP2006/310048 JP2006310048W WO2006123784A1 WO 2006123784 A1 WO2006123784 A1 WO 2006123784A1 JP 2006310048 W JP2006310048 W JP 2006310048W WO 2006123784 A1 WO2006123784 A1 WO 2006123784A1
Authority
WO
WIPO (PCT)
Prior art keywords
iodine
sheet
substrate
compound
antibacterial
Prior art date
Application number
PCT/JP2006/310048
Other languages
French (fr)
Japanese (ja)
Inventor
Hirokazu Shiga
Nobuhiro Taguchi
Akio Maeda
Original Assignee
Nippoh Chemicals Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippoh Chemicals Co., Ltd. filed Critical Nippoh Chemicals Co., Ltd.
Priority to CN2006800171526A priority Critical patent/CN101175405B/en
Priority to JP2007516353A priority patent/JPWO2006123784A1/en
Publication of WO2006123784A1 publication Critical patent/WO2006123784A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/12Iodine, e.g. iodophors; Compounds thereof

Definitions

  • the present invention relates to an antibacterial composition and an antibacterial material. Specifically, the present invention relates to an antibacterial composition and an antibacterial material containing iodine.
  • Microbes such as various bacteria and molds exist in our living space. These organisms can cause us to feel uncomfortable, causing food rot and odors. In addition, the human body causes various diseases such as food poisoning. In order to live a hygienic life, it is important to suppress the growth of these microorganisms or to remove these microorganisms.
  • iodine tends to sublime even at room temperature. For this reason, if iodine is used alone for applications such as antibacterial and deodorizing, there is a problem that sufficient effects cannot be obtained by sublimation of iodine.
  • PVP polyvinylpyrrolidone
  • ovidone iodine
  • JP-A-5-88625 discloses an iodine-cyclodextrin inclusion complex (hereinafter also referred to as “CDI”) in which an iodine atom is included in a cyclodextrin !
  • CDI iodine-cyclodextrin inclusion complex
  • 2001-89974 discloses a fiber base material in which povidone is held on a fiber surface together with a predetermined polymer.
  • Japanese Patent Application Laid-Open No. 51-100892 discloses a sterilized and antiseptic packaging paper provided with a ⁇ -cyclodextrin inclusion product of iodine.
  • JP-A-63-225308 and JP-A-2-110 disclose a powder having a property of foaming by reacting with an iodine carrier, an iodide, an oxidizing agent, a powdered acid and, if necessary, a powdered acid.
  • a solid odor hall composition (formulation) containing a base is disclosed. According to these techniques, a solid squeeze hole composition (formulation) that is easy to manufacture and stable can be provided.
  • an antibacterial material for example, a sheet-like antibacterial material
  • a certain amount of iodine is sublimated from the base material surface and held on the base material. Reduced iodine concentration.
  • the antibacterial action also decreased over time, and as a result, the antibacterial action sometimes disappeared.
  • the substrate surface force can also sublimate iodine because the sterilization and antiseptic mechanism of the wrapping paper described in Reference 6 is based on sublimated iodine (I) released into the package space.
  • iodine is triiodide ion (I-) or pentaiodine.
  • the strong iodide ion ( ⁇ ) is once again transferred to the Eodohole carrier (for example, poly
  • the Eodohole carrier for example, poly
  • the antibacterial activity disappears after almost a certain time.
  • the antibacterial material exhibits an iodine color, and there is a problem in appearance when applied to a product labeled “antibacterial”.
  • there is a repulsive force S in which iodine color adheres to the object to be processed or corrosion of the object to be processed occurs.
  • an object of the present invention is to provide a means that enables effective use of iodine in an antibacterial material using iodine.
  • the present inventors have conducted intensive research to solve the above problems. In the process, if an excessive amount of an iodine-based oxidant such as iodate is present in an iodine-based compound such as an iodide salt, iodine is produced after exhibiting antibacterial properties.
  • an oxidizing agent other than an iodine-based oxidizing agent is used in the antibacterial composition or antibacterial material of the present invention, a small amount of coexisting iodine-based compounds are instantly oxidized and the reaction is terminated. After I— and I— are consumed over time, Since the regeneration is not performed, the antibacterial composition and the antibacterial material are exhausted, and the effects of the present invention cannot be obtained. Further, in all of the examples described in the above documents, the content of iodine-based oxidant is less than the content of S-iodine compound (iodide). Can hardly be expected.
  • an iodine compound (A), an iodine oxidant (B), and an acid compound (C), the iodine compound (A ) And the iodine-based oxidizing agent (B) in a mass ratio of (B) / (A) 1 to: LOOO.
  • the solid substrate is preferably a sheet-like substrate or a granular substrate.
  • the above antibacterial composition and antibacterial material can be used as an antibacterial agent for rugs, dipping, filters, wiping, spraying, or filling.
  • FIG. 1 is a cross-sectional view showing a preferred embodiment of an antibacterial material of a second embodiment.
  • FIG. 2 is a cross-sectional view showing a preferred position embodiment of the antibacterial material of the second embodiment, which is a laminated sheet-like antibacterial material.
  • FIG. 3 is a view showing a state of manufacturing a laminated sheet-like antibacterial material of a second embodiment.
  • the iodine compound (A), the iodine oxidant (B), and the oxide compound (C) are contained, and the iodine compound (A) and the iodine oxidant are included.
  • antibacterial is a concept that means that the growth of microorganisms is suppressed by iodine. This concept includes a bactericidal action in which microorganisms are killed by iodine and a slight effect by iodine.
  • Microorganisms whose growth is suppressed by the antibacterial composition of this embodiment and the antibacterial material described below are not particularly limited, and include viruses and fungi in addition to bacteria.
  • the antibacterial composition of the present embodiment first contains an iodine compound (A).
  • the “iodine-based compound” means a compound that can generate iodide ions ( ⁇ ) upon contact with moisture, an organic solvent, or in some cases, air. In this way, it is oxidized to I- and I- by the action of iodine-based oxidant 14 described in detail later, and exhibits antibacterial action.
  • iodine-based compound means a compound that can generate iodide ions ( ⁇ ) upon contact with moisture, an organic solvent, or in some cases, air. In this way, it is oxidized to I- and I- by the action of iodine-based oxidant 14 described in detail later, and exhibits antibacterial action.
  • the compound contained in the boron-based oxidant (B) is not included in the concept of the iodine-based compound (A).
  • the specific type of the iodine-based compound (A) is not particularly limited as long as it is a compound exhibiting the above-described action.
  • examples include iodide salts such as potassium iodide (KI) and sodium iodide (Nal).
  • KI potassium iodide
  • Na sodium iodide
  • I iodine molecules alone
  • disulfide compound (A) it may be used as a disulfide compound (A).
  • iodine compounds (A) may be used alone or two or more of them may be used in combination.
  • the antibacterial composition of this embodiment contains an iodine-based oxidizing agent (B).
  • the “iodine-based oxidant” means an activity capable of oxidizing ⁇ generated from the above iodine-based compound (A) to I— or I—.
  • ⁇ _ hypoiodite ion
  • IO- iodate ion
  • IO- periodate ion
  • the amount of I— and I— is kept at a low concentration throughout.
  • the iodine-based oxidizing agent (B) not only functions as a source of the active species but also contains iodine through the reactions of the above reaction formulas (1) to (3). It also functions as a supply source. Therefore, according to the present invention, by employing a compound containing iodine as an oxidant for oxidizing iodide ions to form a silicon molecule, the effect of the present invention for effective use of iodine is further improved. It can be further demonstrated. As described above, these effects cannot be obtained when an oxidizing agent other than iodine-based oxidizing agents is used.
  • the specific type of the iodine-based oxidizing agent (B) is not particularly limited as long as it is a compound that can generate the active species by contact with moisture.
  • examples include iodic acids such as hypoiodous acid (HIO), iodic acid (HIO), paraperiodic acid (HIO), periodic acid (HIO),
  • Iodine salts such as 3 and iodic acid (I 0), iodine trioxide (I O), iodine pentoxide (I o),
  • Iodic acid compounds such as silicon (I ⁇ ) and iodine tetroxide (IO). These iodine
  • elemental oxidant (B) only one kind may be used alone, or two or more kinds may be used in combination.
  • the antibacterial composition of the present embodiment thirdly contains an acid compound (C).
  • acid compound means contact with moisture. It means a compound that can make the water more acidic.
  • salts of strong acids and weak bases can be mentioned.
  • the acid compound includes citrate monohydrate, succinic acid, malic acid, oxalic acid, tartaric acid and the like. Derivatives such as these hydrates may be used.
  • the oxides include salts of strong and weak bases such as ammonium chloride, ammonium sulfate, and ammonium iodide, as well as acid salts such as sodium hydrogen sulfate and phosphorus.
  • Potassium dihydrogen acid, basic salts such as salt, sodium hydroxide, and magnesium can be used.
  • acid compounds (C) only 1 type may be used independently and 2 or more types may be used together.
  • each component contained in the antibacterial composition of the present embodiment has been described above, but the content of each component in the antibacterial composition is not particularly limited, and the above chemical reaction formula ( It can be adjusted as appropriate by considering the stoichiometric ratio, production method, presence or absence of additives in (1) to (3).
  • the content of each component contained in the antibacterial composition is not particularly limited as long as the above-mentioned regulations are satisfied.
  • the content of the iodine compound (A) is preferably 0 with respect to the total amount of the composition as long as the iodine produced by oxidation is sufficient to exhibit an antibacterial action.
  • the content of the iodine-based acid additive (B) is controlled so that the mass ratio with the iodine-based compound (A) is a value within the above range.
  • the content of the iodine-based oxidant (B) is preferably 1 to 95% by mass, more preferably 5 to 90% by mass, and further preferably 10 to 80% with respect to the total amount of the composition. % By mass.
  • the content of the acid compound (C) is preferably 1 to 95% by mass, more preferably 5 to 90% by mass, and further preferably 10 to 80% by mass with respect to the total amount of the composition. It is.
  • the initial amount and regeneration amount of iodine i.e., the amount of iodine concentration maintained
  • the amount of the iodine concentration maintained becomes too large, improving the corrosivity and color tone, and reducing the concentration at low concentrations.
  • the effects of the present invention, such as stabilization of iodine may not be sufficiently exhibited.
  • the content of the iodine-based oxidant (B) is too large, the amount of the acid compound (C) necessary to consume all the iodine-based oxidant (B) will increase, and antibacterial activity will occur. There is a possibility that the acidity of the sexual composition may increase excessively. If various additives described later are added, the contents of (A) to (C), which are essential components in the antibacterial composition, may be out of the above-mentioned range. However, it can be included in the technical scope of the present invention.
  • JP-A-2000-507217, JP-A-59-202248, JP-A-56-99419, JP-A-53-148540, etc. also disclose iodine-based compounds and iodine-based compounds. Disinfectant compositions comprising an oxidizing agent and an acid compound are disclosed. However, in the techniques described in these documents, iodine-based oxidizers are added for the purpose of stabilizing separately added iodine and iodine holes. In combination with a silicon-based oxidant, I
  • the antibacterial composition of the present embodiment may further contain other additives as required! There are no particular restrictions on specific forms of other additives, and conventionally known findings can be referred to as appropriate.
  • Preferable additives include, for example, compounds that can form a complex with iodine.
  • the compound that can form a complex with iodine include cyclodextrin (CD), polyvinylpyrrolidone (PVP), glycine, and the like. Add these compounds As a result, the sublimation and corrosion properties of iodine are alleviated. Of these, cyclodextrin is preferably included.
  • the cyclodextrin additive provides a deodorizing effect by including various compounds in the pollutant in its own cyclic structure.
  • “Cyclodextrin” is a compound in which D-glucose is bound cyclically by ⁇ -1,4 bonds. Cyclodextrins are broadly classified into 6 cyclodextrin (6), ⁇ -cyclodextrin (7), and ⁇ -cyclodextrin (8) according to the number of D-glucose that constitutes it. Any of these may be used in the antibacterial composition of this embodiment.
  • cyclodextrin is not particularly limited, and a conventionally known form can be appropriately employed. Of course, not only the above three cyclodextrins but also derivatives thereof may be used. Examples of cyclodextrin derivatives include alkylated (methylated, ethylated, propylated, isopropylated, butylated, etc.), monoacetylated, triacetylated, monochlorotriazinylated. Specific examples of cyclodextrin include those commercially available as CAVAMAX (registered trademark) series and CAVASOL (registered trademark) series (both manufactured by Sakka).
  • cyclodextrins such as a maltosyl group-substituted cyclodextrin commercially available as Dextrin Pearl or Isoelite (manufactured by Yokohama International Bio-Laboratory Co., Ltd.) may be used. Of these cyclodextrins, only one kind may be used alone, or two or more kinds may be used in combination.
  • the cyclodextrin contained in the antibacterial composition can exert a deodorizing action by including various compounds in the contaminants in its cyclic structure.
  • cyclodextrin is produced by the above mechanism I- or I-
  • iodine-cyclodextrin inclusion compound which is a kind of iodine hole. Therefore, when I— or I— decomposes, it becomes I and sublimates.
  • the antibacterial durability will be improved when the antibacterial composition is used.
  • the cyclodextrin mono-iodine inclusion complex in which part or all of the cyclodextrin is initially included in the inclusion of iodine is also included. Also good.
  • the antimicrobial composition of this form can form a complex with iodine.
  • the content of the compound that can form a complex with the iodine is not particularly limited, but is preferably 0 to 90% by mass, more preferably 0 to 80%, based on the total amount of the composition. % By mass, more preferably 0 to 70% by mass.
  • the antibacterial composition of the present embodiment may contain a known antibiotic or synthetic antibacterial if necessary.
  • known antibiotics include, for example, penicillins, cefems, strong rubapenems, monobatams, etc. —lactam antibiotics; aminoglycoside antibiotics; macrolide antibiotics; tetracycline antibiotics Chloramphenicol; lincomycin; fosfomycin; peptide antibiotics; and antifungal antibiotics.
  • Examples of synthetic antibacterial agents include naliditasic acid, new quinolone antibacterial agents, and azole antifungal agents.
  • the various compounds used as an external preparation and a disinfectant can be added as an additive. In some cases, an antiviral agent may be added.
  • only one kind may be used alone, or two or more kinds may be used in combination.
  • the antibacterial composition of the present embodiment may be a powdery composition obtained by mixing the above-described essential components (i) to (C) and an additive as necessary.
  • An aqueous solution-like composition further containing According to the form of the aqueous solution, there are advantages that handling and storage are easy and that the applicable range is widened because it can be used by spraying or spraying.
  • the amount of water added is not particularly limited, but is preferably 1 to 2000 times by mass, more preferably 2 to 1000 times the total amount of components other than water. It is mass times, More preferably, it is 20-500 mass times. However, it is needless to say that a form outside these ranges may be adopted.
  • the production method of the antibacterial composition of the present embodiment is not particularly limited, and conventionally known knowledge relating to the production of a powdery composition or an aqueous solution composition can be appropriately referred to.
  • a powdery composition prepares the components of the composition, and then granulate or pulverize each prepared component to the desired particle size and mix homogeneously with a mixer! ⁇ method.
  • granulation and pulverization may be performed simultaneously with mixing.
  • an aqueous composition is produced !, in the case where a predetermined amount of components of the composition is weighed, added to water, and dissolved by stirring.
  • other methods may be used.
  • a granular antibacterial material in which a granular substrate as described below is used as a solid substrate is also included in the technical scope of the present invention.
  • FIG. 1 is a cross-sectional view showing one preferred embodiment of the antibacterial material of the present embodiment.
  • the antibacterial material in the form shown in FIG. That is, the sheet-like substrate 12 is used as the solid substrate.
  • an iodine-based compound (A) 14, an iodine-based oxidant (B) 16, and an oxidized compound (C) 18 are held inside a sheet-like base material 12. It has the composition which becomes.
  • each component is held only inside the sheet-like base material 12, but is not limited to such a form.
  • each of the above components is held only on the surface of the sheet-like base material 12 or a form in which both of the components are held on the inside and the surface of the sheet-like base material 12 can also be adopted. Further, when each component is held on the surface of the sheet-like substrate 12, it may be held only on one side of the sheet-like substrate 12, or may be held on both sides of the sheet-like substrate 12. ,.
  • the sheet-like antibacterial material 10 having the form shown in FIG. 1 includes a sheet-like substrate 12 as a solid substrate.
  • the specific form of the sheet-like substrate 12 is not particularly limited.
  • Examples of the constituent material of the sheet-like substrate 12 used for the sheet-like antibacterial material 10 of this embodiment include paper, woven fabric, and non-woven fabric.
  • paper Japanese paper, filter paper, drawing paper, high-quality paper, cardboard paper, cardboard Recycled paper, synthetic paper, white paperboard, yellow paperboard, chipball, colored paperboard, building material base paper, backing paper, thin paper, thermal paper, synthetic fiber paper, etc. are included.
  • Either organic fiber or inorganic fiber may be used as a raw material for the woven fabric and the nonwoven fabric.
  • the organic fibers include plant fibers, animal fibers, regenerated fibers, semi-synthetic fibers, synthetic fibers, and the like.
  • inorganic fibers include glass fibers, carbon fibers, ceramic fibers, and the like.
  • Sarayoko and plant fibers include wood pulp, straw pulp, bamboo pulp, kenaf pulp, and other woods, herbs, cotton, hemp, etc.
  • Animal fibers include silk, wool, etc. Fiber.
  • Examples of recycled fibers include rayon and cuvula.
  • Examples of semi-synthetic fibers include acetate, triacetate, and promix.
  • synthetic fibers include nylon, acrylic, vinylon, vinylidene, polyvinyl chloride, polyester, polyethylene, and polypropylene. , Benzoate, polyclar
  • the sheet-like base material 12 a commercially available one may be used, or a self-synthesized one may be used.
  • the size and shape of the sheet-like substrate 12 can also be appropriately determined according to the use of the sheet-like antibacterial material, which is not particularly limited.
  • the content of each component is controlled so that the content of the iodine-based oxidizing agent (B) is equal to or higher than the content of the iodine-based compound (A)
  • This mechanism proceeds well and iodine contained in the antibacterial material can be effectively used.
  • the content of each component contained therein is not particularly limited as long as the above-mentioned regulations are satisfied.
  • the content of iodine compound (A) is sufficient depending on the type of solid substrate (for example, non-woven fabric or paper) as long as the concentration of iodine generated by oxidation is sufficient to exhibit antibacterial action.
  • the specific gravity can vary accordingly, so it is difficult to define it unambiguously.
  • the content of the iodine-based compound (A) is preferably from 0.0001 to 20% by mass relative to the total amount of the antibacterial material. Preferably it is 0.0001-5 mass%, More preferably, it is 0.0001-1 mass%.
  • the content of the silicon-based oxidant (B) is controlled so that the mass ratio with the iodine-based compound (A) is a value within the above range, and further, For product (C), use an amount sufficient to react all the iodine-based acid oxidants (B).
  • the antibacterial material can be visually identified as before or after use.
  • iodine can be reused by the mechanism described above. Therefore, even when it is iodine color and is identified as “after use”, it can sufficiently exhibit antibacterial action.
  • additives may be further retained on the solid substrate as necessary.
  • examples of the additive that can be further retained on the solid substrate include the additives described in the column of the antibacterial composition of the first embodiment.
  • iodine exhibits an antibacterial effect
  • iodine color is similar in color to common contaminants.
  • the sheet-like base material 12 holds starch or a derivative thereof in the sheet-like antibacterial material 10 of the present embodiment. According to the form of force, when I— or I— is generated by the above mechanism,
  • I- and I- are starches and their derivatives.
  • the solid substrate is paper
  • Various fillers such as diatomaceous earth and acid titanium, dyes such as garlic, pigments such as chrome yellow, various sizing agents such as rosin, starch, rice bran, carboxymethylcellulose, polyvinyl alcohol, glycerin Brighteners, surfactants, fragrances, etc. Dyes, pigments, etc.
  • the solid substrate is a nonwoven fabric made of fiber
  • an antistatic agent, a stabilizer, an anti-yellowing agent, a lubricant and the like can be retained.
  • the sheet-like antibacterial material 10 of the present embodiment may be dried or wet.
  • the viewpoint power of reducing the corrosiveness to metals and improving the stability of iodine is preferably dry.
  • the impregnating liquid impregnated in the sheet-like antibacterial material 10 include water, water-containing alcohol, and surfactant.
  • the sheet-like antibacterial material 10 of the present embodiment may be a laminated type! / ⁇ .
  • Examples of the form of the laminated sheet-like antibacterial material 10 include the form shown in FIG. FIG. 2 is a cross-sectional view showing a laminated sheet-like antibacterial material.
  • the sheet-like antibacterial material 10 includes a first sheet-like material 10A and a second sheet-like material 10B.
  • the first sheet-like material 10A has a configuration in which only the iodine compound (A) 14 is held on the first sheet-like substrate 12A.
  • the second sheet-like material 10B has a configuration in which the iodine-based oxidizing agent (B) 16 and the acid compound (C) 18 are held on the second sheet-like base material 12B.
  • the laminated sheet-like antibacterial material 10 in which the iodine compound (A) 14 and the iodine oxidant (B) 16 are held on separate solid substrates is used. It is preferable because it hardly exhibits iodine color before.
  • I the laminated sheet-like antibacterial material 10 in which the iodine compound (A) 14 and the iodine oxidant (B) 16 are held on separate solid substrates. It is preferable because it hardly exhibits iodine color before.
  • the technical scope of the present invention is not limited only to the form in which the iodine color exhibited by the sheet-like antibacterial material 10 is thinned.
  • the reason why the iodine color exhibited by the sheet-like antibacterial material 10 having the form shown in FIG. 2 is reduced will be described in detail in the column of the production method below.
  • the acid compound (C) 18 is held on a solid substrate different from the iodine compound (A) 14, in other words, the iodine oxidant (B) is held.
  • the iodine compound (A) power iodine (I— or I ") due to the influence of the acid compound (C)
  • each sheet-like material (10A, 10B) constituting the sheet-like antibacterial material 10 having the form shown in FIG. 2 and each sheet-like substrate (12A, 12B) which is the main body of each sheet-like material are provided. Crowned
  • first and second mean that iodine-based compound 14, iodine-based oxidizing agent 16 and acid compound 18 are held on separate sheet-like substrates, respectively. It is only used for convenience to show that each sheet is composed of a separate sheet of material. Therefore, the “first” and “second” orders themselves have no special meaning.
  • the raw material of the first sheet-like base material 12A and the raw material of the second sheet-like base material 12B may be the same or different.
  • the form in which each component is held on the sheet-like base material is not limited to the form shown in FIG. Can be adopted.
  • the iodine compound (A) and the iodine acid oxidizing agent (B) are held on the first sheet-like substrate, and the acid compound (C) is the second compound.
  • Iodine-based compound (A) and acid compound (C) are held on the first sheet-like substrate, and iodine-based oxidant (B) is the second sheet.
  • Iodine compound (A) is held on the first sheet-like substrate and iodine-based oxidant (B) is held on the second sheet-like substrate.
  • any form such as a form in which the acid compound (C) is held on the third sheet-like substrate (however, the order of stacking the first to third sheet-like substrates is not limited) It can be adopted.
  • the sheet-like antibacterial material 10 of this embodiment is further provided with a sheet other than the sheet-like antibacterial material of this embodiment on one or both sides of the sheet-like antibacterial material 10 of the form shown in FIGS. It may be a laminated sheet formed. As described above, the sheet-like antibacterial material of this embodiment may exhibit an iodine color when used. In such a case, by forming a laminated sheet laminated with another sheet, the sheet-like antibacterial material of the present embodiment exhibiting iodine color can be coated and the appearance can be improved.
  • the contaminants including microorganisms attached to the surface of the stacked sheet can diffuse to the layer of the sheet-like antibacterial material of this embodiment, so that the antibacterial action can be sufficiently exerted.
  • the sheet-like antibacterial material 10 of the form shown in FIG. 2 the sheet-like antibacterial material and the material in this embodiment are configured between the first sheet-like material 10A and the second sheet-like material 10B. Sheets other than the sheet to be performed may be further arranged. Antibacterial action can be fully exerted even in powerful laminated sheets.
  • the sheet-like antibacterial material of this embodiment is a laminated sheet
  • the sheet that can be disposed in addition to the sheet-like antibacterial material of this embodiment is particularly limited.
  • a sheet that also serves as a base material that can be used in the present embodiment can be adopted.
  • the method for producing the sheet-like antibacterial material 10 of the present embodiment is not particularly limited.
  • the sheet-like antibacterial material 10 having the form shown in FIG. 1 is prepared by, for example, preparing an immersion solution containing components to be retained, immersing the sheet-like base material 12 in the solution, taking out and drying it. It can be manufactured by a method. Hereinafter, it demonstrates in order of a process.
  • an appropriate solvent is prepared, and the above-mentioned iodine-based compound (A) 14, iodine-based oxidizing agent (B) 16, and acid compound (C) 18 are added to the prepared solvent.
  • the components to be held may be added simultaneously to the dipping solution.
  • other additives such as stabilizers may be added for the purpose of changing the properties of the solution based on known knowledge.
  • the solvent to be prepared is not particularly limited, and water, ethanol, methanol, toluene, ethyl acetate, acetone, tetrahydrofuran, dimethyl sulfoxide, and a mixed solvent thereof can be used. However, from the viewpoint of being able to sufficiently dissolve each of the above components, water or a solvent containing water as a main component can be preferably used.
  • the separately prepared sheet-like substrate 12 is immersed in the immersion solution prepared above.
  • each component contained in the dipping solution is held inside and on the surface of the sheet-like substrate 12.
  • the sheet-like base material 12 is taken out and dried with a dipping solution force.
  • a dipping solution force There are no particular restrictions on the specific drying method, natural drying may be used, or forced drying by heating or blowing may be used. There are no particular restrictions on the temperature conditions and the drying time during heating, and it may be set as appropriate with reference to known knowledge.
  • any method may be employed when the solution prepared above is applied to the surface of the sheet-like substrate 12 by a method such as spray coating or roll attachment. Then, after applying the same drying process Yes.
  • the sheet-like antibacterial material 10 in a form in which each component in the solution is held on the surface of the sheet-like substrate 12 can be produced.
  • a method may be adopted in which the raw material of the sheet-like substrate 12 is further added to the above immersion solution and paper is made.
  • the sheet-like antibacterial material having the configuration shown in FIG. 2 can be manufactured. That is, in this embodiment, the first sheet-like substrate is immersed in a solution in which the iodine-based compound (A) is dissolved in a solvent, and the iodine-based compound (A) is added to the first sheet-like substrate.
  • the step of holding, the second sheet-like substrate is immersed in a solution in which the iodine-based oxidizing agent (B) and the acid compound (C) are dissolved in a solvent, and the second sheet-like substrate is A step of retaining the iodine-based oxidizing agent (B) and the acid compound (C), a step of drying the first sheet-like substrate and the second sheet-like substrate, and the first sheet. And a step of laminating the second sheet-shaped substrate and the second sheet-shaped substrate.
  • Figure 3 shows how a laminated sheet-like antibacterial material is manufactured by the manufacturing method of this embodiment.
  • the production method of the present embodiment separately includes an immersion solution containing an iodine-based compound (A) and an immersion solution containing an iodine-based oxidizing agent (B) and an acid compound (C). Except for preparing the sheet-like antibacterial material 10 by laminating each sheet-like base material 12 by laminating each sheet-like base material 12 by immersing a separate sheet-like base material 12 in each of them, It is the same as that of said manufacturing method about the sheet-like antibacterial material of the form shown to.
  • the sheet-like antibacterial material 10 of the form shown in FIG. 2 produced by the production method of the present embodiment exhibits almost no iodine color before use. This is explained as follows.
  • the sheet-like antibacterial material 10 exhibits a certain iodine color.
  • each component to be retained does not coexist in the immersion solution at a time. Therefore, I-, I-, and I showing iodine color are not generated. For this reason, the manufacturing method of this embodiment
  • the sheet-like antibacterial material produced in this way rarely shows an iodine color before use. Therefore, according to the manufacturing method of the present embodiment, an aesthetically preferable sheet-like antibacterial material 10 can be manufactured. Furthermore, since there is no I- or I- in the manufacturing process,
  • each of the first sheet-like base material 12A and the second sheet-like base material 12B is made to hold desired components and then laminated to form a laminated sheet.
  • Antimicrobial material 10 At this time, after each sheet-like substrate 12 is also taken out of each immersion solution force, it may be laminated before drying, and dried after lamination, or each sheet-like substrate 12 may be taken out from each immersion solution, and then each The sheet-like substrate 12 may be dried and laminated after drying. From the point of view that I-, I-, and I are not generated by the mechanism described above,
  • a laminated form can be preferably adopted.
  • the method of laminating when the sheet-like base materials 12 are laminated to form a laminated sheet is not particularly limited, and conventionally known methods can be appropriately employed in the field of producing laminated sheets.
  • the lamination method it is preferable to consider that the component held on the first sheet-like substrate 12A and the component held on the second sheet-like substrate 12B hardly react at the time of lamination.
  • the laminating method for example, there is a method in which the first sheet-like substrate 12A and the second sheet-like substrate are laminated to form a laminated body, and only the peripheral part of the laminated body is thermally bonded. It is done. Of course, other methods may be adopted.
  • the sheet-like antibacterial material 10 of the present embodiment can be applied to various uses by appropriately adjusting the amount of each component retained and the form of a solid substrate.
  • the contaminant adheres to the sheet-shaped antibacterial material 10 of this embodiment, and moisture in the adhered contaminants.
  • Iodine ions ( ⁇ ) generated by contact with iodine, iodine-based oxidants (IO_, IO-I, IO-), and
  • Ton (H +) produces I- and I- by the mechanism shown in the chemical reaction formulas (1) to (3) above.
  • the microorganisms contained therein can be effectively sterilized. That is, an antibacterial action is exhibited.
  • a specific application of the sheet-like antibacterial material 10 of the present embodiment is, for example, a toilet Laid on the floor of the toilet as a laboratory mat; laid on a laboratory table or floor as a laboratory table, and placed on a laboratory table or floor; laid on a work table or floor in a medical institution as a medical sheet;
  • a kitchen paper for rugs such as laying on a kitchen workbench or floor, as a soaking sterilization sheet, for soaking in a solution contaminated by microorganisms, as a filter
  • filters for air conditioners, air cleaners, and vacuum cleaners but are not limited to these. Of course, it may be used for wiping off contaminants in various places as described above.
  • the configuration of the antibacterial material of the present invention and the manufacturing method thereof have been described in detail by taking as an example a sheet-like antibacterial material using a sheet-like base material as a solid substrate. It should be determined based on the description of the scope of claims, and is not limited to the sheet form.
  • Examples of forms other than the sheet form of the antibacterial material of the present embodiment include a granular form in which a granular base material is used as a solid base material. That is, the present application also provides an antibacterial material whose solid substrate is a granular substrate.
  • the antibacterial material of the present embodiment is the same as the above-described sheet-like antibacterial material except that the solid substrate has a granular shape. Therefore, detailed description is omitted here.
  • the particle size of the granular substrate is not particularly limited, and can be appropriately determined according to the use of the granular antibacterial material.
  • each component described in the column of the first embodiment is included in the granular base material.
  • the iodine compound (A), the iodine oxidant (B), and the acid compound (C) may all be held on the same granular base material.
  • This form conceptually corresponds to the sheet-like antibacterial material shown in FIG.
  • the particulate antibacterial material of the present embodiment includes a first particulate material in which the iodine compound (A) is held on the first particulate substrate, and an iodine oxidant on the second particulate substrate.
  • iodine compound (A) and iodine oxidant (B) are held on the first granular base material, and acid compound (C) is the second.
  • the iodine compound (A) and the acid compound (C) are held on the first granular substrate, and the iodine oxidant (B) is the second granular substrate.
  • Iodine compound (A) is held on the first granular substrate, iodine oxidant (B) is held on the second granular substrate, and acid compound (C ) Is held on the third granular base material, and any form can be adopted such as a form in which these granular base materials are mixed homogeneously.
  • the shape and size of the granular substrate are not particularly limited.
  • the shape of the granular base material may be spherical, or a rectangular parallelepiped shape or an indefinite shape.
  • the size is small enough to be referred to as granular, and in addition to lumps and solids, large sizes that can give an impression can also be used as granular substrates.
  • the method for producing the antibacterial material of this embodiment is not particularly limited.
  • the granular antibacterial material of this embodiment can be manufactured by replacing the solid substrate to be used from a sheet-like substrate with a granular substrate. Further, the iodine compound (A) is held on the first granular substrate and the iodine-based oxidant (on the second granular substrate) according to the same idea as the method of manufacturing the antibacterial material of the second embodiment described above.
  • a mixed granular antibacterial material can be produced by retaining the B) and the acid compound (C) and mixing the first granular substrate and the second granular substrate in which the respective components are retained. .
  • the antibacterial material of this form which is granular can be applied to various uses by the same mechanism as the sheet-like antibacterial material by appropriately adjusting the content of each component and the form of the solid substrate. And can exhibit antibacterial properties. In this case, iodine can be used effectively.
  • antibacterial material of the present embodiment which is granular include, for example, for rugs such as pet toilet sand laid on the bottom of pet toilets; When filling the inside of the container, there are forms for filling, etc., but it is not limited to these.
  • Water iodine compound potassium iodide is (A) (KI) (0. 109 mass%), potassium iodate is iodine Sani ⁇ agent (B) (KIO) (1. 0 mass 0/0) , Acid compound (C)
  • iodide ion ( ⁇ ) present in the aqueous solution is constantly regenerated into iodine (I— and I—).
  • the laminated sheet-like antibacterial material shown in FIG. 2 was produced by the following method according to the production method shown in FIG.
  • water was prepared as a solvent for the first immersion solution.
  • This water iodine compounds potassium iodide is (A) (KI) (0. 109 mass 0/0), as well as, a-CD (3. 0 mass 0/0) cyclodextrin (CD) and and ⁇ Ka ⁇ the methyl-beta-CD (2. 0 mass 0/0), and uniformly mixed by stirring to prepare a first dip solution.
  • a second immersion solution was prepared by adding citric acid monohydrate (2.0% by mass) and methyl- ⁇ CD (5.0% by mass) as described above, and mixing uniformly by stirring. .
  • a commercially available pulp woven fabric manufactured by Sun 'Japan Co., Ltd .; "Paper Chemical Thick Skin Thick" was cut into a total size of 5 cm x 5 cm, and the first and first 2 sheet-like base materials were prepared.
  • the first and second sheet-like base materials prepared above are immersed in the first and second immersion solutions prepared above, respectively, and left at 25 ° C for 1 minute. Each component therein was held on a sheet-like substrate.
  • each sheet-like substrate was taken out from each dipping solution, and these were applied to hot air at 80 ° C for 30 minutes by a dryer to dry each sheet-like substrate.
  • the antibacterial material of the present invention can exert an antibacterial action even when it comes into contact with contaminants.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Disclosed is means for effectively utilizing iodine in an anti-bacterial material. An anti-bacterial composition comprising (A) an iodine-containing compound, (B) an iodine-containing oxidizing agent and (C) an acid compound, the iodine-containing compound (A) and the iodine-containing oxidizing agent (B) being contained at a ratio by mass: (B)/(A) = 1 to 1000; and an anti-bacterial material comprising a solid substrate and (A) an iodine-containing compound, (B) an iodine-containing oxidizing agent and (C) an acid compound retained within or on the surface of the solid substrate, the iodine-containing compound (A) and the iodine-containing oxidizing agent (B) being contained at a ratio by mass: (B)/(A) = 1 to 1000.

Description

明 細 書  Specification
抗菌性組成物および抗菌性材料  Antibacterial composition and antibacterial material
技術分野  Technical field
[0001] 本発明は、抗菌性組成物および抗菌性材料に関する。詳細には、本発明は、ヨウ 素を含有する抗菌性組成物および抗菌性材料に関する。  [0001] The present invention relates to an antibacterial composition and an antibacterial material. Specifically, the present invention relates to an antibacterial composition and an antibacterial material containing iodine.
背景技術  Background art
[0002] 我々の生活空間には、種々の細菌ゃカビ等の微生物が存在している。これらの微 生物は、食物の腐敗や悪臭の発生の原因となって、我々に不快感を与えることがあ る。また、人体に対しては、食中毒を初めとして種々の疾病を引き起こす原因となる。 衛生的な生活を送るためには、これらの微生物の増殖を抑制し、またはこれらの微生 物を除去することが重要である。  [0002] Microbes such as various bacteria and molds exist in our living space. These organisms can cause us to feel uncomfortable, causing food rot and odors. In addition, the human body causes various diseases such as food poisoning. In order to live a hygienic life, it is important to suppress the growth of these microorganisms or to remove these microorganisms.
[0003] かかる観点から、従来、清潔な生活空間を提供することを目的として、種々の提案 がなされている。その一つとして、ヨウ素が注目を集めている。これは、ヨウ素が広範 な抗菌スペクトルを有する一方で、ヒトに対する安全性も高ぐ優れた抗菌性を有して 、ることによる。  [0003] From this point of view, various proposals have been made for the purpose of providing a clean living space. As one of them, iodine is attracting attention. This is because iodine has a broad antibacterial spectrum, while having excellent antibacterial properties that are highly safe for humans.
[0004] し力しながら、ヨウ素は常温においても昇華しやすい。このため、ヨウ素を単体のま ま抗菌や消臭といった用途に用いると、ヨウ素の昇華によって充分な効果が得られな いという問題がある。  [0004] However, iodine tends to sublime even at room temperature. For this reason, if iodine is used alone for applications such as antibacterial and deodorizing, there is a problem that sufficient effects cannot be obtained by sublimation of iodine.
[0005] このような欠点を補うベぐヨウ素の揮発性の低減などを目的として、種々のョードホ ールが提案されている(例えば、特公昭 60— 19762号公報、米国特許第 2739922 号明細書、米国特許第 3028300号明細書、および特開昭 51— 88625号公報を参 照)。ョードホールの具体例として、特公昭 60— 19762号公報には、担体であるキト サンとヨウ素との複合体が開示されている。また米国特許第 2739922号明細書およ び米国特許第 3028300号明細書には、担体であるポリビニルピロリドン (PVP)とヨウ 素との複合体 (以下、「ポビドンョード」とも称する)が開示されている。そして特開昭 5 1— 88625号公報には、ヨウ素原子がシクロデキストリンに包接されてなるヨウ素—シ クロデキストリン包接ィ匕合物(以下、「CDI」とも称する)が開示されて!、る。 [0006] そして、これらのョードホールを基材に保持させることにより基材に抗菌性を付与し 、抗菌性材料とする試みがなされている。例えば、特開 2001— 89974号公報には、 ポビドンョードが所定のポリマーとともに繊維表面に保持されてなる繊維基材が開示 されている。また、特開昭 51— 100892号公報〖こは、ヨウ素の β—シクロデキストリン 包接物を設けてなる殺菌、防腐包装紙が開示されている。 [0005] Various iodine holes have been proposed for the purpose of reducing the volatility of vegetative iodine to compensate for these disadvantages (for example, Japanese Patent Publication No. 60-19762, US Pat. No. 2739922). U.S. Pat. No. 3028300 and JP-A-51-88625). As a specific example of the odor hole, Japanese Patent Publication No. 60-19762 discloses a complex of chitosan and iodine as a carrier. In addition, U.S. Pat. No. 2739922 and U.S. Pat. No. 3028300 disclose a composite of polyvinylpyrrolidone (PVP), which is a carrier, and iodine (hereinafter also referred to as “Povidone”). . JP-A-5-88625 discloses an iodine-cyclodextrin inclusion complex (hereinafter also referred to as “CDI”) in which an iodine atom is included in a cyclodextrin !, The [0006] An attempt has been made to impart antibacterial properties to the base material by holding these pseudo holes on the base material to obtain an antibacterial material. For example, Japanese Unexamined Patent Publication No. 2001-89974 discloses a fiber base material in which povidone is held on a fiber surface together with a predetermined polymer. Japanese Patent Application Laid-Open No. 51-100892 discloses a sterilized and antiseptic packaging paper provided with a β-cyclodextrin inclusion product of iodine.
[0007] 特開 2001— 89974号公報および特開昭 51— 100892号公報に記載の技術のよ うに、ョードホールの形態でヨウ素を繊維基材に保持させれば、ヨウ素を単体で用い る場合と比較してヨウ素の昇華が抑制され、抗菌や消臭といった効果の持続性は向 上しうる。  [0007] Like the techniques described in JP-A-2001-89974 and JP-A-51-100892, if iodine is held on a fiber substrate in the form of a odor hole, iodine is used alone. In comparison, sublimation of iodine is suppressed, and the sustainability of antibacterial and deodorizing effects can be improved.
[0008] なお、特開昭 63— 225308号公報および特開平 2— 110号公報には、ヨウ素担体 、ヨウ化物、酸化剤および粉末酸および必要により粉末酸と反応して発泡する性質を もつ粉末塩基を含有する固形ョードホール組成物 (製剤)が開示されて ヽる。これら の技術によれば、製造が簡単で、安定な固形ョードホール組成物 (製剤)が提供され うる。  JP-A-63-225308 and JP-A-2-110 disclose a powder having a property of foaming by reacting with an iodine carrier, an iodide, an oxidizing agent, a powdered acid and, if necessary, a powdered acid. A solid odor hall composition (formulation) containing a base is disclosed. According to these techniques, a solid squeeze hole composition (formulation) that is easy to manufacture and stable can be provided.
発明の開示  Disclosure of the invention
[0009] しカゝしながら、ョードホールが基材に保持されてなる抗菌性材料 (例えば、シート状 抗菌性材料)においても、やはり一定量のヨウ素が基材表面から昇華し、基材に保持 されるヨウ素濃度は遁減する。その結果、抗菌作用も経時的に遁減し、ひいては抗菌 作用が消失してしまう場合もあった。なお、基材表面力もヨウ素が昇華しうることは、前 記文献 6に記載の包装紙の殺菌や防腐のメカニズムが、包装物空間中に放出された 昇華ヨウ素 (I )を介するものであることからも明らかである。  [0009] However, even in an antibacterial material (for example, a sheet-like antibacterial material) in which a hooded hole is held on a base material, a certain amount of iodine is sublimated from the base material surface and held on the base material. Reduced iodine concentration. As a result, the antibacterial action also decreased over time, and as a result, the antibacterial action sometimes disappeared. The substrate surface force can also sublimate iodine because the sterilization and antiseptic mechanism of the wrapping paper described in Reference 6 is based on sublimated iodine (I) released into the package space. It is clear from
2  2
[0010] ところで、上記のョードホールにおいては、ヨウ素が三ヨウ化物イオン (I―)や五ヨウ  [0010] By the way, in the above hole, iodine is triiodide ion (I-) or pentaiodine.
3 化物イオン (I ")の形態で含有されて 、ると考えられて 、る。  It is thought that it is contained in the form of trioxide ion (I ").
5  Five
[0011] ョードホール中にかようなイオンの形態で含有されるヨウ素力 汚染物などとの接触 により殺菌作用を発揮する際には、当該汚染物中の細菌、真菌、原虫、ウィルスとい つた微生物や、有機物などとの反応によりこれらのイオンが還元され、ヨウ化物イオン (Γ)が生成する。  [0011] When sterilizing action is exerted by contact with iodine power pollutants, etc. contained in the form of ions such as in the horde hall, microorganisms such as bacteria, fungi, protozoa, viruses in the pollutants and These ions are reduced by reaction with organic substances and iodide ions (Γ) are generated.
[0012] し力しながら、力 うなヨウ化物イオン (Γ)が再度ョードホールの担体 (例えば、ポリ ビュルピロリドンゃシクロデキストリン)に取り込まれてョードホールを再生することはほ とんどなぐ一定時間経過後には抗菌活性が消失してしまう。一方で、充分な効果を 得る目的で製剤に高濃度のョードホールを添加すると、抗菌性材料がヨウ素色を呈 し、「抗菌性」と銘打った商品に適用するには外観上問題がある。また、使用時にお いても、被処理物に対してヨウ素色が付着したり、被処理物の腐食が生じたりする虡 力 Sある。し力しながら、このような問題があっても、抗菌性材料を一定期間の使用に処 するためには、外観や腐食の問題は度外視して最初力 効果発現に必要な量に比 ベて過剰量のヨウ素(I )を存在させる必要があった。 [0012] However, the strong iodide ion (Γ) is once again transferred to the Eodohole carrier (for example, poly When it is taken up into bullpyrrolidone (cyclodextrin) and regenerates hordeol, the antibacterial activity disappears after almost a certain time. On the other hand, if a high concentration of hordehole is added to the preparation for the purpose of obtaining a sufficient effect, the antibacterial material exhibits an iodine color, and there is a problem in appearance when applied to a product labeled “antibacterial”. In addition, even during use, there is a repulsive force S in which iodine color adheres to the object to be processed or corrosion of the object to be processed occurs. However, in order to treat the antibacterial material for a certain period of time even if there is such a problem, the problem of appearance and corrosion should be ignored and compared with the amount required for the first effect. An excess of iodine (I) had to be present.
2  2
[0013] 従って、ヨウ素を利用する抗菌性材料において、含まれるヨウ素を有効に利用し、 低濃度のヨウ素を長期間に亘つて維持するための技術の開発が望まれているのが現 状である。  [0013] Therefore, in an antibacterial material using iodine, it is currently desired to develop a technology for effectively using the contained iodine and maintaining a low concentration of iodine over a long period of time. is there.
[0014] そこで本発明は、ヨウ素を利用する抗菌性材料におけるヨウ素の有効利用を可能と する手段を提供することを目的とする。  [0014] Therefore, an object of the present invention is to provide a means that enables effective use of iodine in an antibacterial material using iodine.
[0015] 本発明者らは、上記の課題を解決すベぐ鋭意研究を行った。その過程で、ヨウ素 酸塩のようなヨウ素系酸化剤を、ヨウ化物塩のようなヨウ素系化合物に対して過剰量 共存させると、ヨウ素が抗菌性を発揮した後に生成する I—から I I  [0015] The present inventors have conducted intensive research to solve the above problems. In the process, if an excessive amount of an iodine-based oxidant such as iodate is present in an iodine-based compound such as an iodide salt, iodine is produced after exhibiting antibacterial properties.
3—や 5—を再生でき、さ らには、ヨウ素系酸化剤をヨウ素の供給源としても作用させうることを知得した。さらに は、添加するヨウ素系化合物の量に呼応して生成および再生する I I  It was learned that 3- and 5- could be regenerated, and that iodine-based oxidants could also act as iodine sources. Furthermore, it is generated and regenerated in response to the amount of iodine compound added.
3—および 5—の量 が決定されることを利用して、少量のヨウ素系化合物を添加することにより低濃度のョ ゥ素 (I—および I―)を長期間に亘つて安定的に保ちうることを知得した。すなわち、 Taking advantage of the determination of the amount of 3— and 5—, low concentrations of iodine (I— and I—) can be kept stable over long periods of time by adding small amounts of iodine compounds. I knew that. That is,
3 5 3 5
力 うな構成とすることにより、ヨウ素の有効利用が図られることを見出し、本発明を完 成させるに至ったのである。なお、上述した特開昭 63— 225308号公報および特開 平 2—110号公報に記載の固形ョードホール組成物 (製剤)においては、ヨウ素系の 酸化剤を必須とする後述の知見については述べられておらず、ヨウ素系酸化剤はョ ゥ化物イオン (Γ)を酸化するために列挙された多数の酸化剤の一例として記載され ているに過ぎない。一方、仮に本発明の抗菌性組成物や抗菌性材料においてヨウ素 系酸化剤以外の酸化剤を用いた場合には、共存する少量のヨウ素系化合物が瞬時 に全て酸化されて反応が終了し、短時間で I—および I—が消費された後はこれらの 再生もなされないため、抗菌性組成物や抗菌性材料の寿命が尽き、本発明の作用 効果は心得られない。さらに、上記文献に記載の実施例においてはいずれもヨウ素 系酸化剤の含有量力 Sヨウ素系化合物 (ヨウ化物)の含有量よりも少ないことから、ヨウ 素を有効利用するといつた本願発明の作用効果はほとんど期待できない。 The inventors have found that effective use of iodine can be achieved by adopting a powerful configuration, and have completed the present invention. In addition, in the solid sward-hole composition (formulation) described in JP-A-63-225308 and JP-A-2-110 described above, the following knowledge that an iodine-based oxidizing agent is essential is described. However, iodine-based oxidants are only listed as examples of the many oxidants listed to oxidize iodide ions (Γ). On the other hand, if an oxidizing agent other than an iodine-based oxidizing agent is used in the antibacterial composition or antibacterial material of the present invention, a small amount of coexisting iodine-based compounds are instantly oxidized and the reaction is terminated. After I— and I— are consumed over time, Since the regeneration is not performed, the antibacterial composition and the antibacterial material are exhausted, and the effects of the present invention cannot be obtained. Further, in all of the examples described in the above documents, the content of iodine-based oxidant is less than the content of S-iodine compound (iodide). Can hardly be expected.
[0016] 具体的には、本発明の一形態によれば、ヨウ素系化合物 (A)と、ヨウ素系酸化剤( B)と、酸化合物 (C)と、を含み、前記ヨウ素系化合物 (A)と前記ヨウ素系酸化剤 (B) との含有量の質量比が(B) / (A) = 1〜: LOOOである、抗菌性組成物が提供される。  [0016] Specifically, according to one aspect of the present invention, an iodine compound (A), an iodine oxidant (B), and an acid compound (C), the iodine compound (A ) And the iodine-based oxidizing agent (B) in a mass ratio of (B) / (A) = 1 to: LOOO.
[0017] また、本発明の他の形態によれば、固体基材と、前記固体基材の内部または表面 に保持された、ヨウ素系化合物 (A)、ヨウ素系酸化剤 (B)、および酸化合物 (C)と、を 含み、前記ヨウ素系化合物 (A)と前記ヨウ素系酸化剤 (B)との含有量の質量比が (B )Z(A) = 1〜: LOOOである、抗菌性材料が提供される。ここで、前記固体基材はシ一 ト状基材または粒状基材であることが好ましい。さらに、上記の抗菌性組成物や抗菌 性材料は、敷物用、浸漬用、フィルタ用、拭き取り用、噴霧用、または充填用の抗菌 剤として用いられうる。  [0017] Further, according to another embodiment of the present invention, a solid base material, an iodine-based compound (A), an iodine-based oxidant (B), and an acid held inside or on the surface of the solid base material A compound (C), wherein the mass ratio of the content of the iodine compound (A) and the iodine oxidant (B) is (B) Z (A) = 1: LOOO Material is provided. Here, the solid substrate is preferably a sheet-like substrate or a granular substrate. Furthermore, the above antibacterial composition and antibacterial material can be used as an antibacterial agent for rugs, dipping, filters, wiping, spraying, or filling.
[0018] 本発明のさらに他の目的、特徴および特質は、以後の説明および添付図面に例示 される好ましい実施の形態を参酌することによって、明らかになるであろう。  [0018] Further objects, features, and characteristics of the present invention will become apparent by referring to the following description and preferred embodiments illustrated in the accompanying drawings.
図面の簡単な説明  Brief Description of Drawings
[0019] [図 1]第 2実施形態の抗菌性材料の好ましい一実施形態を示す断面図である。 FIG. 1 is a cross-sectional view showing a preferred embodiment of an antibacterial material of a second embodiment.
[0020] [図 2]積層型のシート状抗菌性材料である、第 2実施形態の抗菌性材料の好ましい位 置実施形態を示す断面図である。 FIG. 2 is a cross-sectional view showing a preferred position embodiment of the antibacterial material of the second embodiment, which is a laminated sheet-like antibacterial material.
[0021] [図 3]第 2実施形態の積層型のシート状抗菌性材料を製造する様子を示す図である。 [0021] FIG. 3 is a view showing a state of manufacturing a laminated sheet-like antibacterial material of a second embodiment.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0022] (第 1実施形態) [0022] (First embodiment)
本発明の一形態によれば、ヨウ素系化合物 (A)と、ヨウ素系酸化剤 (B)と、酸化合 物 (C)と、を含み、前記ヨウ素系化合物 (A)と前記ヨウ素系酸化剤 (B)との含有量の 質量比が (B)Z(A) = 1〜: LOOOである、抗菌性組成物が提供される。なお、本発明 において「抗菌性」とは、ヨウ素により微生物の増殖が抑制されることを意味する概念 である。この概念には、ヨウ素により微生物が殺滅される殺菌作用と、ヨウ素により微 生物の生存状態は維持されるものの増殖は抑えられる静菌作用とのいずれもが含ま れる。本形態の抗菌性組成物や後述する抗菌性材料により増殖が抑制される微生 物は特に制限されず、細菌以外にもウィルスや真菌などが含まれる。 According to one aspect of the present invention, the iodine compound (A), the iodine oxidant (B), and the oxide compound (C) are contained, and the iodine compound (A) and the iodine oxidant are included. An antibacterial composition is provided in which the mass ratio of the content to (B) is (B) Z (A) = 1 to: LOOO. In the present invention, “antibacterial” is a concept that means that the growth of microorganisms is suppressed by iodine. This concept includes a bactericidal action in which microorganisms are killed by iodine and a slight effect by iodine. These include both the bacteriostatic action that maintains the living state of the organism but suppresses its growth. Microorganisms whose growth is suppressed by the antibacterial composition of this embodiment and the antibacterial material described below are not particularly limited, and include viruses and fungi in addition to bacteria.
[0023] 以下、本形態の好ましい実施形態を、構成成分ごとに詳細に説明するが、本発明 の技術的範囲が下記の具体的な形態のみに限定されることはない。  [0023] Hereinafter, preferred embodiments of the present invention will be described in detail for each component, but the technical scope of the present invention is not limited to the following specific forms.
[0024] [ヨウ素系化合物 (A) ]  [0024] [Iodine compound (A)]
本形態の抗菌性組成物は、第 1に、ヨウ素系化合物 (A)を含む。ここで、「ヨウ素系 化合物」とは、水分や有機溶媒、場合によっては空気などと接触してヨウ化物イオン( Γ)を生成しうる化合物を意味する。この ΙΊま、後に詳述するヨウ素系酸化剤 14の作 用により I—や I—へと酸化され、抗菌作用を発揮するようになる。ただし、後述するョ  The antibacterial composition of the present embodiment first contains an iodine compound (A). Here, the “iodine-based compound” means a compound that can generate iodide ions (Γ) upon contact with moisture, an organic solvent, or in some cases, air. In this way, it is oxidized to I- and I- by the action of iodine-based oxidant 14 described in detail later, and exhibits antibacterial action. However,
3 5  3 5
ゥ素系酸化剤 (B)に含まれる化合物は、当該ヨウ素系化合物 (A)の概念には含まな いものとする。  The compound contained in the boron-based oxidant (B) is not included in the concept of the iodine-based compound (A).
[0025] ヨウ素系化合物 (A)の具体的な種類については、上述の作用を示す化合物であれ ばよぐ特に制限はない。一例としては、ヨウ化カリウム (KI)やヨウ化ナトリウム (Nal) 等のヨウ化物塩などが挙げられる。なお、場合によっては、ヨウ素分子の単体 (I )をョ  [0025] The specific type of the iodine-based compound (A) is not particularly limited as long as it is a compound exhibiting the above-described action. Examples include iodide salts such as potassium iodide (KI) and sodium iodide (Nal). In some cases, iodine molecules alone (I)
2 ゥ素系化合物 (A)として用いてもよい。また、これらのヨウ素系化合物 (A)は、 1種の みが単独で用いられてもよ!/ヽし、 2種以上が併用されてもょ ヽ。  It may be used as a disulfide compound (A). In addition, only one of these iodine compounds (A) may be used alone or two or more of them may be used in combination.
[0026] [ヨウ素系酸化剤 (B) ] [0026] [Iodine-based oxidizing agent (B)]
本形態の抗菌性組成物は、第 2に、ヨウ素系酸化剤 (B)を含む。ここで、「ヨウ素系 酸化剤」とは、上記のヨウ素系化合物 (A)から生成した Γを I—や I—へと酸ィ匕しうる活  Secondly, the antibacterial composition of this embodiment contains an iodine-based oxidizing agent (B). Here, the “iodine-based oxidant” means an activity capable of oxidizing Γ generated from the above iodine-based compound (A) to I— or I—.
3 5  3 5
性種を生成しうる化合物を意味する。前記活性種の具体例としては、例えば、次亜ョ ゥ素酸イオン (ιο_)、ヨウ素酸イオン (IO―)、および過ヨウ素酸イオン (IO―)が挙げ  It means a compound capable of producing a sex species. Specific examples of the active species include hypoiodite ion (ιο_), iodate ion (IO-), and periodate ion (IO-).
3 4 られる。これらのイオンは、水分との接触により濃度の増加した rを酸ィ匕して I—や I "  3 4 These ions are oxidized by increasing the concentration of r by contact with moisture, I— and I “
3 5 に変換する。この機構を詳細に説明すると、 ΙΊま、各活性種の作用により、下記化学 反応式 (1)〜(3):  3 Convert to 5. To explain this mechanism in detail, the following chemical reaction formulas (1) to (3):
[0027] [化 1] [0027] [Chemical 1]
I 0 _ + I - + 2 H +→ I 2 + H 2 0 ( 1 ) I 0 _ + I-+ 2 H + → I 2 + H 2 0 (1)
3 I 0 3— + I _ + 1 8 H +→2 I 2 + 9 H 2 0 · · ( 2 ) 3 I 0 3 — + I _ + 1 8 H + → 2 I 2 + 9 H 2 0 (2)
I 0 4— + I— + 8 H +→ I 2 + 4 H 2 0 ( 3 ) [0028] に従ってヨウ素分子 (I )に酸化され、さらに、水中の他の厂との反応により、 I—や I " I 0 4 — + I— + 8 H + → I 2 + 4 H 2 0 (3) [0028] Oxidized to iodine molecules (I) in accordance with I- and I "
2 3 5 を生じる。このようにして生成した I—や I—は、再び抗菌作用を発揮しうる。すなわち、  2 3 5 is generated. The I— and I— produced in this way can exert antibacterial action again. That is,
3 5  3 5
ヨウ素の有効利用が図られるのである。さらに、再生される I—や I—の量は厂の量に  Effective utilization of iodine is achieved. In addition, the amount of I- and I-
3 5  3 5
依存するため、本形態の抗菌性組成物によれば I—や I—の量を終始低濃度に保つ  Therefore, according to the antibacterial composition of this embodiment, the amount of I— and I— is kept at a low concentration throughout.
3 5  3 5
ことが可能である。その結果、抗菌性組成物の長寿命化が可能となり、腐蝕性や色 調の問題からも開放されうる。なお、上記のメカニズムはあくまでも推測に過ぎず、上 記以外のメカニズムによって本発明の作用効果が得られて ヽるとしても、本発明の技 術的範囲は何ら影響を受けることはな 、。  It is possible. As a result, it is possible to extend the life of the antibacterial composition, and it can be freed from corrosion and color problems. It should be noted that the above mechanism is merely a guess, and the technical scope of the present invention is not affected at all even if the effects of the present invention can be obtained by mechanisms other than those described above.
[0029] なお、本発明にお ヽて、ヨウ素系酸化剤 (B)は上記活性種の供給源として機能す るのみならず、上記の反応式(1)〜(3)の反応を通じて、ヨウ素の供給源としても機 能する。よって本発明によれば、ヨウ素を含む化合物を、ヨウ化物イオンを酸化してョ ゥ素分子を生成させるための酸化剤として採用することにより、ヨウ素の有効利用とい う本発明の作用効果がより一層発揮されうる。なお、ヨウ素系酸化剤以外の酸化剤を 用いた場合には、これらの効果が得られないことは上述した通りである。  [0029] In the present invention, the iodine-based oxidizing agent (B) not only functions as a source of the active species but also contains iodine through the reactions of the above reaction formulas (1) to (3). It also functions as a supply source. Therefore, according to the present invention, by employing a compound containing iodine as an oxidant for oxidizing iodide ions to form a silicon molecule, the effect of the present invention for effective use of iodine is further improved. It can be further demonstrated. As described above, these effects cannot be obtained when an oxidizing agent other than iodine-based oxidizing agents is used.
[0030] ヨウ素系酸化剤 (B)の具体的な種類についても特に制限はなぐ水分との接触によ り上記の活性種を生成しうる化合物であればよい。一例としては、次亜ヨウ素酸 (HIO )、ヨウ素酸 (HIO )、パラ過ヨウ素酸 (HIO )、過ヨウ素酸 (H IO )等のヨウ素酸類、  [0030] The specific type of the iodine-based oxidizing agent (B) is not particularly limited as long as it is a compound that can generate the active species by contact with moisture. Examples include iodic acids such as hypoiodous acid (HIO), iodic acid (HIO), paraperiodic acid (HIO), periodic acid (HIO),
3 4 5 6  3 4 5 6
前記ヨウ素酸類の金属塩 (例えば、ナトリウム塩、カリウム塩等)、 I (IO )  Metal salts of the above iodic acids (for example, sodium salt, potassium salt, etc.), I (IO)
3 3等のヨウ素 塩、および、亜ヨウ素酸 (I 0)、三酸化ヨウ素 (I O )、五酸化ヨウ素 (I o )、七酸化ョ  3 Iodine salts such as 3 and iodic acid (I 0), iodine trioxide (I O), iodine pentoxide (I o),
2 2 3 2 5 ゥ素 (I Ο )、四酸化ヨウ素 (IO )等のヨウ素酸ィ匕物が挙げられる。なお、これらのヨウ 2 2 3 2 5 Iodic acid compounds such as silicon (I Ο) and iodine tetroxide (IO). These iodine
2 7 4 2 7 4
素系酸化剤(B)は、 1種のみが単独で用いられてもよいし、 2種以上が併用されても よい。  As the elemental oxidant (B), only one kind may be used alone, or two or more kinds may be used in combination.
[0031] [酸化合物(C) ]  [0031] [Acid compound (C)]
化学反応式(1)〜(3)からわ力るように、厂から I—や I—が生成するメカニズムにお  As can be seen from the chemical reaction formulas (1) to (3), the mechanism of I— and I— generation from soot
3 5  3 5
いては、水素イオンが消費される。従って、本形態の抗菌性組成物が水分と接触した 際に I—や I—が生成するためには、上記メカニズムが進行するために、本形態の抗 In this case, hydrogen ions are consumed. Therefore, in order for I- and I- to be generated when the antibacterial composition of this embodiment comes into contact with moisture, the above mechanism proceeds, so
3 5 3 5
菌性組成物と接触した水分が、酸性を示す必要がある。このため、本形態の抗菌性 組成物は、第 3に、酸化合物(C)を含む。ここで、「酸ィ匕合物」とは、水分との接触に より当該水分を酸性としうる化合物を意味する。例えば、酸のほか、強酸と弱塩基との 塩などが挙げられる。酸ィ匕合物の具体例についても特に制限はないが、一例を挙げ ると、酸としては、クェン酸一水和物、コハク酸、リンゴ酸、シユウ酸、酒石酸などが挙 げられる。これらの水和物などの誘導体が用いられてもよい。また、酸以外の酸化合 物としては、塩化アンモ-ゥム、硫酸アンモ-ゥム、ヨウ化アンモ-ゥム等の強酸と弱 塩基との塩のほか、酸性塩である硫酸水素ナトリウム、リン酸二水素カリウム、塩基性 塩である塩ィ匕水酸ィ匕マグネシウムなどが用いられうる。なお、これらの酸化合物(C) は、 1種のみが単独で用いられてもよいし、 2種以上が併用されてもよい。 Moisture in contact with the fungal composition must be acidic. For this reason, the antibacterial composition of the present embodiment thirdly contains an acid compound (C). Here, “acid compound” means contact with moisture. It means a compound that can make the water more acidic. For example, in addition to acids, salts of strong acids and weak bases can be mentioned. There are no particular restrictions on the specific examples of the acid compound, but as an example, the acid includes citrate monohydrate, succinic acid, malic acid, oxalic acid, tartaric acid and the like. Derivatives such as these hydrates may be used. In addition to the acid, the oxides include salts of strong and weak bases such as ammonium chloride, ammonium sulfate, and ammonium iodide, as well as acid salts such as sodium hydrogen sulfate and phosphorus. Potassium dihydrogen acid, basic salts such as salt, sodium hydroxide, and magnesium can be used. In addition, as for these acid compounds (C), only 1 type may be used independently and 2 or more types may be used together.
[0032] 以上、本形態の抗菌性組成物に含まれる各成分の具体的な構成を説明したが、抗 菌性組成物における各成分の含有量は特に制限されず、上記の化学反応式(1)〜 (3)における化学量論比や製造手法、添加剤の有無などを考慮することにより、適宜 調節されうる。ただし、本形態の抗菌性組成物においては、ヨウ素系化合物 (A)とョ ゥ素系酸化剤 (B)との含有量の比が所定の範囲内の値に制御される。具体的には、 ヨウ素系化合物 (A)とヨウ素系酸化剤 (B)との含有量の質量比が、(B) Z (A) = 1〜 1000となるように制御される。このように、ヨウ素系酸化剤(B)の含有量がヨウ素系化 合物 (A)の含有量以上となるように、各成分の含有量が制御されると、上記のメカ- ズムが良好に進行し、組成物中に含まれるヨウ素が有効に利用されうる。また、好まし くは(8) 7 (八)= 5〜200でぁり、ょり好ましくは(8) 7 (八)= 10〜100でぁる。ここで 、(B) Z (A)の値が小さすぎると、上記化学反応式(1)〜(3)で表される反応が進む 回数が減少する結果、ヨウ素の再生が短期間で終了してしまい、ヨウ素の有効利用を 図るという本願発明の作用効果が十分に得られない虞がある。  [0032] The specific configuration of each component contained in the antibacterial composition of the present embodiment has been described above, but the content of each component in the antibacterial composition is not particularly limited, and the above chemical reaction formula ( It can be adjusted as appropriate by considering the stoichiometric ratio, production method, presence or absence of additives in (1) to (3). However, in the antibacterial composition of the present embodiment, the content ratio between the iodine compound (A) and the iodine oxidant (B) is controlled to a value within a predetermined range. Specifically, the mass ratio of the content of the iodine compound (A) and the iodine oxidant (B) is controlled so that (B) Z (A) = 1 to 1000. As described above, when the content of each component is controlled so that the content of the iodine-based oxidizing agent (B) is equal to or greater than the content of the iodine-based compound (A), the above mechanism is good. The iodine contained in the composition can be effectively utilized. Further, (8) 7 (eight) = 5 to 200 is preferable, and (8) 7 (eight) = 10 to 100 is preferable. Here, if the value of (B) Z (A) is too small, the number of times the reactions represented by the chemical reaction formulas (1) to (3) proceed will decrease, so that the regeneration of iodine is completed in a short period of time. As a result, there is a possibility that the effect of the present invention of effectively utilizing iodine cannot be obtained.
[0033] なお、抗菌性組成物に含まれる各成分のそれぞれの含有量は、上記の規定を満 足する限り特に制限されない。ただし、好ましい形態において、ヨウ素系化合物 (A) の含有量は、酸化されて生じたヨウ素が抗菌作用を発現するのに十分な量であれば よぐ組成物の全量に対して、好ましくは 0. 001〜10質量%であり、より好ましくは 0 . 005〜5質量%であり、さらに好ましくは 0. 01〜3質量%である。また、ヨウ素系酸 ィ匕剤 (B)の含有量につ \、ては、ヨウ素系化合物 (A)との質量比が上述の範囲内の値 となるように制御し、さらに酸ィ匕合物(C)については、全てのヨウ素系酸化剤(B)を反 応させるのに十分な量を用いればよい。従って、ヨウ素系酸化剤(B)の含有量は、組 成物の全量に対して、好ましくは 1〜95質量%であり、より好ましくは 5〜90質量%で あり、さらに好ましくは 10〜80質量%である。また、酸化合物(C)の含有量は、組成 物の全量に対して、好ましくは 1〜95質量%であり、より好ましくは 5〜90質量%であ り、さらに好ましくは 10〜80質量%である。ここで、ヨウ素系化合物 (A)の含有量が 多すぎると、ヨウ素の初期量および再生量 (すなわち、ヨウ素濃度の維持量)が多くな りすぎ、腐蝕性や色調の改善、低濃度でのヨウ素の安定化といった本発明の作用効 果が十分に発揮されない虞がある。一方、ヨウ素系酸化剤 (B)の含有量が多すぎると 、ヨウ素系酸化剤 (B)を全て消費するのに必要な酸ィ匕合物 (C)の量が増加することと なり、抗菌性組成物の酸性度が過度に上昇してしまう虞がある。なお、後述する種々 の添加剤を添加すると、抗菌性組成物中の必須成分である (A)〜(C)の含有量が 上述した範囲カゝら外れる場合もありうるが、かような場合であっても本発明の技術的 範囲に包含されうる。 [0033] The content of each component contained in the antibacterial composition is not particularly limited as long as the above-mentioned regulations are satisfied. However, in a preferred form, the content of the iodine compound (A) is preferably 0 with respect to the total amount of the composition as long as the iodine produced by oxidation is sufficient to exhibit an antibacterial action. 001 to 10% by mass, more preferably 0.005 to 5% by mass, and still more preferably 0.01 to 3% by mass. In addition, the content of the iodine-based acid additive (B) is controlled so that the mass ratio with the iodine-based compound (A) is a value within the above range. For products (C), all iodine-based oxidants (B) A sufficient amount may be used to adapt. Accordingly, the content of the iodine-based oxidant (B) is preferably 1 to 95% by mass, more preferably 5 to 90% by mass, and further preferably 10 to 80% with respect to the total amount of the composition. % By mass. In addition, the content of the acid compound (C) is preferably 1 to 95% by mass, more preferably 5 to 90% by mass, and further preferably 10 to 80% by mass with respect to the total amount of the composition. It is. Here, if the content of iodine compound (A) is too large, the initial amount and regeneration amount of iodine (i.e., the amount of iodine concentration maintained) becomes too large, improving the corrosivity and color tone, and reducing the concentration at low concentrations. The effects of the present invention, such as stabilization of iodine, may not be sufficiently exhibited. On the other hand, if the content of the iodine-based oxidant (B) is too large, the amount of the acid compound (C) necessary to consume all the iodine-based oxidant (B) will increase, and antibacterial activity will occur. There is a possibility that the acidity of the sexual composition may increase excessively. If various additives described later are added, the contents of (A) to (C), which are essential components in the antibacterial composition, may be out of the above-mentioned range. However, it can be included in the technical scope of the present invention.
[0034] なお、特開 2000— 507217号公報、特開昭 59— 202248号公報、特開昭 56— 9 9419号公報、特開昭 53— 148540号公報などにも、ヨウ素系化合物、ヨウ素系酸化 剤および酸化合物を含む殺菌性の組成物が開示されている。しカゝしながら、これらの 文献に記載の技術において、ヨウ素系酸化剤は、別途添加したヨウ素やョードホール を安定化させる目的で添加されているのであって、少量のヨウ素系化合物と大量のョ ゥ素系酸化剤との組み合わせによって、 I  [0034] It should be noted that JP-A-2000-507217, JP-A-59-202248, JP-A-56-99419, JP-A-53-148540, etc. also disclose iodine-based compounds and iodine-based compounds. Disinfectant compositions comprising an oxidizing agent and an acid compound are disclosed. However, in the techniques described in these documents, iodine-based oxidizers are added for the purpose of stabilizing separately added iodine and iodine holes. In combination with a silicon-based oxidant, I
3 _や I  3 _ and I
5—を低濃度に維持するという本願の 目的および作用効果については、何ら開示も示唆もない。しかも、これらの文献に記 載の発明は、酸化剤としてヨウ素系酸化剤以外のものを用いても同様の効果が期待 できるものであり、ヨウ素系酸化剤は他の酸化剤と並列的に記載されているに過ぎな い。  There is no disclosure or suggestion about the purpose and effect of this application to maintain 5- at a low concentration. In addition, the inventions described in these documents can be expected to have the same effect even when an oxidizing agent other than iodine-based oxidizing agents is used, and iodine-based oxidizing agents are described in parallel with other oxidizing agents. It has only been done.
[0035] 本形態の抗菌性組成物は、必要に応じて他の添加剤をさらに含んでもよ!、。他の 添加剤の具体的な形態についても特に制限はなぐ従来公知の知見が適宜参照さ れうる。好ましい添加剤としては、例えば、ヨウ素と複合体を形成しうる化合物が挙げ られる。ヨウ素と複合体を形成しうる化合物としては、例えば、シクロデキストリン (CD) 、ポリビニルピロリドン (PVP)、グリシンなどが挙げられる。これらの化合物を添加する ことにより、ヨウ素の昇華性や腐蝕性が緩和される。なかでも、好ましくはシクロデキス トリンが含まれる。シクロデキストリンの添カ卩は、上述の効果にカ卩えて、汚染物中の各 種の化合物を自身の環状構造中に包接することによる消臭効果をもたらす。「シクロ デキストリン」とは、 D グルコースが α— 1, 4結合により環状に結合したィ匕合物であ る。シクロデキストリンは、自身を構成する D グルコースの数によって、 ひ シクロデ キストリン(6個)、 β—シクロデキストリン(7個)、および γ—シクロデキストリン(8個) に大きく分類される。本形態の抗菌性組成物においては、これらのうちのいずれが用 いられてもよい。 [0035] The antibacterial composition of the present embodiment may further contain other additives as required! There are no particular restrictions on specific forms of other additives, and conventionally known findings can be referred to as appropriate. Preferable additives include, for example, compounds that can form a complex with iodine. Examples of the compound that can form a complex with iodine include cyclodextrin (CD), polyvinylpyrrolidone (PVP), glycine, and the like. Add these compounds As a result, the sublimation and corrosion properties of iodine are alleviated. Of these, cyclodextrin is preferably included. In addition to the above-mentioned effects, the cyclodextrin additive provides a deodorizing effect by including various compounds in the pollutant in its own cyclic structure. “Cyclodextrin” is a compound in which D-glucose is bound cyclically by α-1,4 bonds. Cyclodextrins are broadly classified into 6 cyclodextrin (6), β-cyclodextrin (7), and γ-cyclodextrin (8) according to the number of D-glucose that constitutes it. Any of these may be used in the antibacterial composition of this embodiment.
[0036] シクロデキストリンの具体的な形態にっ 、ては特に制限はなぐ従来公知の形態が 適宜採用されうる。上記の 3種のシクロデキストリンのみならず、これらの誘導体が用 いられても、勿論よい。シクロデキストリンの誘導体の例としては、アルキル化 (メチル ィ匕、ェチル化、プロピル化、イソプロピル化、ブチル化など)、モノァセチル化、トリア セチル化、モノクロロトリアジニル化されたものが例示される。シクロデキストリンの具 体例としては、例えば、 CAVAMAX (登録商標)シリーズや CAVASOL (登録商標 )シリーズとして市販されるもの(いずれも、ヮッカー社製)が挙げられる。また、デキシ 一パールやイソエリート (株式会社横浜国際バイオ研究所製)として市販されるマルト シル基置換型シクロデキストリンのような他のシクロデキストリンが用いられてもよい。 なお、これらのシクロデキストリンは、 1種のみが単独で用いられてもよいし、 2種以上 が併用されてもよい。  [0036] The specific form of cyclodextrin is not particularly limited, and a conventionally known form can be appropriately employed. Of course, not only the above three cyclodextrins but also derivatives thereof may be used. Examples of cyclodextrin derivatives include alkylated (methylated, ethylated, propylated, isopropylated, butylated, etc.), monoacetylated, triacetylated, monochlorotriazinylated. Specific examples of cyclodextrin include those commercially available as CAVAMAX (registered trademark) series and CAVASOL (registered trademark) series (both manufactured by Sakka). In addition, other cyclodextrins such as a maltosyl group-substituted cyclodextrin commercially available as Dextrin Pearl or Isoelite (manufactured by Yokohama International Bio-Laboratory Co., Ltd.) may be used. Of these cyclodextrins, only one kind may be used alone, or two or more kinds may be used in combination.
[0037] 上述したように、抗菌性組成物中に含まれるシクロデキストリンは、汚染物中の各種 の化合物を自身の環状構造中に包接することにより、消臭作用を発揮しうる。また、 本形態において、シクロデキストリンは、上記のメカニズムによって生成した I—や I―  [0037] As described above, the cyclodextrin contained in the antibacterial composition can exert a deodorizing action by including various compounds in the contaminants in its cyclic structure. In this form, cyclodextrin is produced by the above mechanism I- or I-
3 5 を包接することによって、ョードホールの 1種であるヨウ素—シクロデキストリン包接化 合物(CDI)を生成しうる。従って、 I—や I—が分解することで Iとなり、昇華してしまう  By inclusion of 35, iodine-cyclodextrin inclusion compound (CDI), which is a kind of iodine hole, can be produced. Therefore, when I— or I— decomposes, it becomes I and sublimates.
3 5 2  3 5 2
虞が低減され、抗菌性組成物の使用時における抗菌持続性の向上が期待される。ま た、場合によっては、本形態の抗菌性組成物において、シクロデキストリンの一部ま たは全部力 当初力もヨウ素を包接してなるシクロデキストリン一ヨウ素包接ィ匕合物の 形態で含まれてもよい。なお、本形態の抗菌性組成物がヨウ素と複合体を形成しうる 化合物を含む場合、当該ヨウ素と複合体を形成しうる化合物の含有量は特に制限さ れないが、組成物の全量に対して、好ましくは 0〜90質量%であり、より好ましくは 0 〜80質量%であり、さらに好ましくは 0〜70質量%である。 It is expected that the antibacterial durability will be improved when the antibacterial composition is used. In some cases, in the antibacterial composition of the present embodiment, the cyclodextrin mono-iodine inclusion complex in which part or all of the cyclodextrin is initially included in the inclusion of iodine is also included. Also good. In addition, the antimicrobial composition of this form can form a complex with iodine. When the compound is contained, the content of the compound that can form a complex with the iodine is not particularly limited, but is preferably 0 to 90% by mass, more preferably 0 to 80%, based on the total amount of the composition. % By mass, more preferably 0 to 70% by mass.
[0038] また、本形態の抗菌性組成物は、必要であれば、公知の抗生物質や合成抗菌剤 などを含んでもよい。公知の抗生物質としては、例えば、ペニシリン系、セフエム系、 力ルバぺネム系、モノバタタム系抗生物質等の —ラクタム系抗生物質;アミノグリコ シド系抗生物質;マクロライド系抗生物質;テトラサイクリン系抗生物質;クロラムフエ二 コール;リンコマイシン;ホスホマイシン;ペプチド系抗生物質;および抗真菌性抗生 物質等が例示される。また、合成抗菌剤としては、ナリジタス酸、ニューキノロン系抗 菌剤、およびァゾール系抗真菌剤等が例示される。なお、これらのみに制限されず、 外用剤や消毒剤として用いられる種々の化合物が添加剤として添加されうる。場合に よっては、抗ウィルス剤が添加されてもよい。また、例示した添加剤は、 1種のみが単 独で用いられてもよぐ 2種以上が併用されてもよい。 [0038] The antibacterial composition of the present embodiment may contain a known antibiotic or synthetic antibacterial if necessary. Known antibiotics include, for example, penicillins, cefems, strong rubapenems, monobatams, etc. —lactam antibiotics; aminoglycoside antibiotics; macrolide antibiotics; tetracycline antibiotics Chloramphenicol; lincomycin; fosfomycin; peptide antibiotics; and antifungal antibiotics. Examples of synthetic antibacterial agents include naliditasic acid, new quinolone antibacterial agents, and azole antifungal agents. In addition, it is not restricted only to these, The various compounds used as an external preparation and a disinfectant can be added as an additive. In some cases, an antiviral agent may be added. In addition, as for the exemplified additives, only one kind may be used alone, or two or more kinds may be used in combination.
[0039] 本形態の抗菌性組成物は、上述した (Α)〜(C)の必須成分および必要に応じた添 加剤が混合されてなる粉末状組成物であってもよ ヽし、水をさらに含んだ水溶液状 の組成物であってもよい。水溶液の形態によれば、取扱いや保存が簡便となったり、 噴霧や散布などによって使用されうるため適用可能な範囲が広がるという利点が得ら れる。なお、本形態の組成物が水をさらに含む場合、水の添加量は特に制限されな いが、水以外の成分の全量に対して、好ましくは 1〜2000質量倍、より好ましくは 2 〜1000質量倍、さらに好ましくは 20〜500質量倍である。ただし、これらの範囲を外 れる形態が採用されても、勿論よい。  [0039] The antibacterial composition of the present embodiment may be a powdery composition obtained by mixing the above-described essential components (i) to (C) and an additive as necessary. An aqueous solution-like composition further containing According to the form of the aqueous solution, there are advantages that handling and storage are easy and that the applicable range is widened because it can be used by spraying or spraying. When the composition of this embodiment further contains water, the amount of water added is not particularly limited, but is preferably 1 to 2000 times by mass, more preferably 2 to 1000 times the total amount of components other than water. It is mass times, More preferably, it is 20-500 mass times. However, it is needless to say that a form outside these ranges may be adopted.
[0040] なお、本形態の抗菌性組成物の製造方法は特に制限されず、粉末状組成物や水 溶液状の組成物の製造に関する従来公知の知見が適宜参照されうる。例えば粉末 状組成物を製造したい場合には、組成物の構成成分を準備し、準備した各成分を適 宜造粒または粉砕して所望の粒径とし、混合機などにより均質に混合すると!ヽぅ手法 が用いられうる。場合によっては、混合と同時に造粒や粉砕が行われてもよい。また、 水溶液状の組成物を製造した!/、場合には、組成物の構成成分の所定量を秤量し、 水に添加して、撹拌により溶解させるという手法が用いられうる。ただし、上述した手 法以外の手法が用いられても、勿論よい。 [0040] The production method of the antibacterial composition of the present embodiment is not particularly limited, and conventionally known knowledge relating to the production of a powdery composition or an aqueous solution composition can be appropriately referred to. For example, if you want to manufacture a powdery composition, prepare the components of the composition, and then granulate or pulverize each prepared component to the desired particle size and mix homogeneously with a mixer!ぅ method can be used. In some cases, granulation and pulverization may be performed simultaneously with mixing. In addition, in the case where an aqueous composition is produced !, in the case where a predetermined amount of components of the composition is weighed, added to water, and dissolved by stirring. However, the hand mentioned above Of course, other methods may be used.
[0041] (第 2実施形態)  [0041] (Second Embodiment)
本発明の他の形態によれば、固体基材と、前記固体基材の内部または表面に保持 された、ヨウ素系化合物 (A)、ヨウ素系酸化剤 (B)、および酸ィ匕合物 (C)と、を含み、 前記ヨウ素系化合物 (A)と前記ヨウ素系酸化剤 (B)との含有量の質量比が (B) / (A ) = 1〜1000である、抗菌性材料が提供される。  According to another aspect of the present invention, a solid substrate, an iodine compound (A), an iodine oxidizer (B), and an acid compound (inside or on the surface of the solid substrate) And an antibacterial material having a mass ratio of the content of the iodine compound (A) and the iodine oxidant (B) of (B) / (A) = 1 to 1000. Is done.
[0042] 以下、本形態の好ましい実施形態を図面を用いて説明する。ただし、本発明の技 術的範囲は、下記の形態や図示する形態によって制限されることはない。例えば、以 下の説明では、固体基材としてシート状基材が用いられたシート状抗菌性材料を例 に挙げて本形態の抗菌性材料を詳細に説明するが、かような形態のみに制限されず Hereinafter, preferred embodiments of the present embodiment will be described with reference to the drawings. However, the technical scope of the present invention is not limited by the following forms or the illustrated forms. For example, in the following explanation, the antibacterial material of this embodiment will be described in detail by taking a sheet-like antibacterial material using a sheet-like substrate as a solid substrate as an example, but it is limited only to such a form. not
、後述するような粒状基材が固体基材として用いられた粒状抗菌性材料もまた、本発 明の技術的範囲に含まれる。 A granular antibacterial material in which a granular substrate as described below is used as a solid substrate is also included in the technical scope of the present invention.
[0043] 図 1は、本形態の抗菌性材料の好ま 、一実施形態を示す断面図である。図 1に 示す形態の抗菌性材料は、シート状抗菌性材料 10である。すなわち、固体基材とし てシート状基材 12が用いられている。図 1に示すシート状抗菌性材料 10は、シート 状基材 12の内部に、ヨウ素系化合物 (A) 14、ヨウ素系酸化剤(B) 16、および酸化合 物 (C) 18が保持されてなる構成を有する。なお、図 1に示す形態において、各成分 はシート状基材 12の内部のみに保持されているが、かような形態のみには制限され ない。例えば、上記の各成分がシート状基材 12の表面のみに保持される形態や、シ ート状基材 12の内部および表面の双方に保持される形態もまた、採用されうる。また 、各成分がシート状基材 12の表面に保持される場合には、シート状基材 12の片面 のみに保持されてもょ 、し、シート状基材 12の両面に保持されてもょ 、。  [0043] FIG. 1 is a cross-sectional view showing one preferred embodiment of the antibacterial material of the present embodiment. The antibacterial material in the form shown in FIG. That is, the sheet-like substrate 12 is used as the solid substrate. In the sheet-like antibacterial material 10 shown in FIG. 1, an iodine-based compound (A) 14, an iodine-based oxidant (B) 16, and an oxidized compound (C) 18 are held inside a sheet-like base material 12. It has the composition which becomes. In the form shown in FIG. 1, each component is held only inside the sheet-like base material 12, but is not limited to such a form. For example, a form in which each of the above components is held only on the surface of the sheet-like base material 12 or a form in which both of the components are held on the inside and the surface of the sheet-like base material 12 can also be adopted. Further, when each component is held on the surface of the sheet-like substrate 12, it may be held only on one side of the sheet-like substrate 12, or may be held on both sides of the sheet-like substrate 12. ,.
[0044] [シート状基材]  [0044] [Sheet substrate]
図 1に示す形態のシート状抗菌性材料 10は、固体基材として、シート状基材 12を 備える。  The sheet-like antibacterial material 10 having the form shown in FIG. 1 includes a sheet-like substrate 12 as a solid substrate.
[0045] シート状基材 12の具体的な形態は、特に制限されない。本形態のシート状抗菌性 材料 10に用いられるシート状基材 12の構成材料としては、例えば、紙、織布、不織 布等が挙げられる。紙には、和紙、濾紙、画用紙、上質紙、ダンボール紙、ボール紙 、再生紙、合成紙、白板紙、黄板紙、チップボール、色板紙、建材原紙、台紙、薄葉 紙、感熱紙、化繊紙等が含まれる。織布および不織布の原料としては、有機繊維お よび無機繊維のいずれが用いられてもよい。ここで、有機繊維には、植物繊維、動物 繊維、再生繊維、半合成繊維および合成繊維等が含まれる。また、無機繊維には、 ガラス繊維、炭素繊維、セラミック繊維等が含まれる。さら〖こ、植物繊維としては、木 材パルプ、藁パルプ、竹パルプ、ケナフパルプ等の木本類のほ力、草本類、綿、麻 等が挙げられ、動物繊維としては、絹、羊毛等の繊維が挙げられる。再生繊維として は、レーヨン、キュブラ等が挙げられ、半合成繊維としては、アセテート、トリアセテート 、プロミックス等が、合成繊維としては、ナイロン、アクリル、ビニロン、ビニリデン、ポリ 塩化ビニル、ポリエステル、ポリエチレン、ポリプロピレン、ベンゾエート、ポリクラール[0045] The specific form of the sheet-like substrate 12 is not particularly limited. Examples of the constituent material of the sheet-like substrate 12 used for the sheet-like antibacterial material 10 of this embodiment include paper, woven fabric, and non-woven fabric. For paper, Japanese paper, filter paper, drawing paper, high-quality paper, cardboard paper, cardboard Recycled paper, synthetic paper, white paperboard, yellow paperboard, chipball, colored paperboard, building material base paper, backing paper, thin paper, thermal paper, synthetic fiber paper, etc. are included. Either organic fiber or inorganic fiber may be used as a raw material for the woven fabric and the nonwoven fabric. Here, the organic fibers include plant fibers, animal fibers, regenerated fibers, semi-synthetic fibers, synthetic fibers, and the like. In addition, inorganic fibers include glass fibers, carbon fibers, ceramic fibers, and the like. Sarayoko and plant fibers include wood pulp, straw pulp, bamboo pulp, kenaf pulp, and other woods, herbs, cotton, hemp, etc. Animal fibers include silk, wool, etc. Fiber. Examples of recycled fibers include rayon and cuvula. Examples of semi-synthetic fibers include acetate, triacetate, and promix. Examples of synthetic fibers include nylon, acrylic, vinylon, vinylidene, polyvinyl chloride, polyester, polyethylene, and polypropylene. , Benzoate, polyclar
、フエノール等の繊維が挙げられる。なお、シート状基材 12としては、巿販のものが 用いられてもよぐ自ら合成したものが用いられてもよ 、。 And fibers such as phenol. In addition, as the sheet-like base material 12, a commercially available one may be used, or a self-synthesized one may be used.
[0046] シート状基材 12の大きさや形状についても特に制限はなぐシート状抗菌性材料 の用途に応じて適宜決定されうる。  [0046] The size and shape of the sheet-like substrate 12 can also be appropriately determined according to the use of the sheet-like antibacterial material, which is not particularly limited.
[0047] なお、シート状基材 12に保持される各成分の種類などの具体的な形態については 、第 1実施形態の欄において説明した通りであるため、ここでは説明を省略する。  [0047] The specific form such as the type of each component held on the sheet-like base material 12 is as described in the column of the first embodiment, and thus the description thereof is omitted here.
[0048] 本形態の抗菌性材料においても、各成分が固体基材に保持される際には、ヨウ素 系化合物 (A)とヨウ素系酸化剤 (B)との含有量の質量比が、 (B) / (A) = 1〜: LOOO となるように制御される。本形態の抗菌性材料においても同様に、ヨウ素系酸化剤 (B )の含有量がヨウ素系化合物 (A)の含有量以上となるように、各成分の含有量が制 御されると、上記のメカニズムが良好に進行し、抗菌性材料中に含まれるヨウ素が有 効に利用されうる。  [0048] Also in the antibacterial material of this embodiment, when each component is held on a solid substrate, the mass ratio of the content of the iodine compound (A) and the iodine oxidant (B) is: B) / (A) = 1 ~: Controlled to be LOOO. Similarly, in the antibacterial material of this embodiment, when the content of each component is controlled so that the content of the iodine-based oxidizing agent (B) is equal to or higher than the content of the iodine-based compound (A), This mechanism proceeds well and iodine contained in the antibacterial material can be effectively used.
[0049] なお、本形態の抗菌性材料にお!、ても、含まれる各成分のそれぞれの含有量は、 上記の規定を満足する限り特に制限されない。例えば、ヨウ素系化合物 (A)の含有 量は、酸化されて生じたヨウ素の濃度が抗菌作用を発現するのに十分な量であれば よぐ固体基材の種類 (例えば、不織布や紙)に応じてその比重も変動しうるため一義 的に規定することは困難である。ただし、好ましい形態において、ヨウ素系化合物 (A )の含有量は、抗菌性材料の全量に対して、好ましくは 0. 00001〜20質量%、より 好ましくは 0. 0001〜5質量%、さらに好ましくは 0. 0001〜1質量%である。また、ョ ゥ素系酸化剤 (B)の含有量につ 1、ては、ヨウ素系化合物 (A)との質量比が上述の範 囲内の値となるように制御し、さらに酸ィ匕合物(C)については、全てのヨウ素系酸ィ匕 剤(B)を反応させるのに十分な量を用いればょ 、。 [0049] Although the antibacterial material of this embodiment is !, the content of each component contained therein is not particularly limited as long as the above-mentioned regulations are satisfied. For example, the content of iodine compound (A) is sufficient depending on the type of solid substrate (for example, non-woven fabric or paper) as long as the concentration of iodine generated by oxidation is sufficient to exhibit antibacterial action. The specific gravity can vary accordingly, so it is difficult to define it unambiguously. However, in a preferred form, the content of the iodine-based compound (A) is preferably from 0.0001 to 20% by mass relative to the total amount of the antibacterial material. Preferably it is 0.0001-5 mass%, More preferably, it is 0.0001-1 mass%. In addition, the content of the silicon-based oxidant (B) is controlled so that the mass ratio with the iodine-based compound (A) is a value within the above range, and further, For product (C), use an amount sufficient to react all the iodine-based acid oxidants (B).
[0050] シート状抗菌性材料 10は、使用時において水分と接触すると、上述のメカニズムに よって I—や I—が生成する。これらのイオンはヨウ素色を呈するため、本形態のシート[0050] When the sheet-like antibacterial material 10 comes into contact with moisture during use, I- and I- are generated by the mechanism described above. Since these ions exhibit iodine color, the sheet of this embodiment
3 5 3 5
状抗菌性材料は、目視によって使用前または使用後のいずれであるかを識別可能 である。ただし、本形態のシート状抗菌性材料 10においては、上述のメカニズムによ りヨウ素が再利用されうる。従って、ヨウ素色を呈して「使用後」であると識別された場 合であっても、充分に抗菌作用を発揮しうる。  The antibacterial material can be visually identified as before or after use. However, in the sheet-like antibacterial material 10 of this embodiment, iodine can be reused by the mechanism described above. Therefore, even when it is iodine color and is identified as “after use”, it can sufficiently exhibit antibacterial action.
[0051] 本形態の抗菌性材料においても、固体基材には必要に応じて他の添加剤がさらに 保持されていてもよい。固体基材にさらに保持されうる添加剤としては、例えば、第 1 実施形態の抗菌性組成物の欄において説明した添加剤が例示されうる。  [0051] Also in the antibacterial material of the present embodiment, other additives may be further retained on the solid substrate as necessary. Examples of the additive that can be further retained on the solid substrate include the additives described in the column of the antibacterial composition of the first embodiment.
[0052] また、本形態においては、他の添加剤もまた、有効に用いられうる。例えば、ヨウ素 が抗菌作用を示すとはいっても、ヨウ素色は一般的な汚染物と色調が類似している。 このため、本形態のシート状抗菌性材料 10を、一旦ヨウ素色を呈した後に再度利用 することは、美観上好ましくない場合も生じうる。力 うな観点力もは、本形態のシート 状抗菌性材料 10において、シート状基材 12にデンプンやその誘導体を保持させる とよい。力ような形態によれば、上述のメカニズムによって I—や I—が生成すると、これ  [0052] In this embodiment, other additives can also be used effectively. For example, although iodine exhibits an antibacterial effect, iodine color is similar in color to common contaminants. For this reason, it may be aesthetically unfavorable to use the sheet-like antibacterial material 10 of the present embodiment once again after exhibiting iodine color. From the viewpoint of strength, it is preferable that the sheet-like base material 12 holds starch or a derivative thereof in the sheet-like antibacterial material 10 of the present embodiment. According to the form of force, when I— or I— is generated by the above mechanism,
3 5  3 5
らはデンプンやその誘導体と複合体を形成し、鮮やかな青紫色を呈する(いわゆる、 「ヨウ素—デンプン反応」)。従って、一旦使用されたシート状抗菌性材料 10の呈色 に起因する美観への悪影響が低減されうる。なお、 I—や I—は、デンプンやその誘導  Form a complex with starch and its derivatives and show a bright blue-purple color (so-called “iodine-starch reaction”). Therefore, the adverse effect on the aesthetics caused by the coloration of the once used sheet-like antibacterial material 10 can be reduced. I- and I- are starches and their derivatives.
3 5  3 5
体と複合体を形成した場合であっても、抗菌作用を発揮しうる。  Even when it forms a complex with the body, it can exhibit antibacterial action.
[0053] さらに他の添加剤としては、例えば、固体基材が紙である場合には、カチオン性デ ンプンまたは両性デンプンを主成分とした内部接着剤、ポリアクリルアミド等の紙力剤 、タルク、ケイソゥ土および酸ィ匕チタン等の各種の填料、ァ-リン等の染料やクロムィ エロー等の顔料、ロジン、デンプン、〖こ力わ、カルボキシメチルセルロース、ポリビ- ルアルコール等の各種のサイジング剤、グリセリン等の光沢剤、界面活性剤、香料、 色素、顔料等が保持されうる。また、固体基材が繊維カゝらなる織布ゃ不織布である場 合には、制電剤、安定剤、黄変防止剤、滑剤等が保持されうる。 [0053] As other additives, for example, when the solid substrate is paper, an internal adhesive mainly composed of cationic dampening or amphoteric starch, a paper strength agent such as polyacrylamide, talc, Various fillers such as diatomaceous earth and acid titanium, dyes such as garlic, pigments such as chrome yellow, various sizing agents such as rosin, starch, rice bran, carboxymethylcellulose, polyvinyl alcohol, glycerin Brighteners, surfactants, fragrances, etc. Dyes, pigments, etc. can be retained. In addition, when the solid substrate is a nonwoven fabric made of fiber, an antistatic agent, a stabilizer, an anti-yellowing agent, a lubricant and the like can be retained.
[0054] 本形態のシート状抗菌性材料 10は、乾燥して 、てもよく、湿潤して 、てもよ 、。ただ し、金属に対する腐食性を低減させ、ヨウ素の安定性を向上させるという観点力 は、 乾燥していることが好ましい。ここで、本形態のシート状抗菌性材料 10が湿潤してい る場合、シート状抗菌性材料 10に含浸される含浸液としては、例えば、水や含水ァ ルコール、界面活性剤等が挙げられる。  [0054] The sheet-like antibacterial material 10 of the present embodiment may be dried or wet. However, the viewpoint power of reducing the corrosiveness to metals and improving the stability of iodine is preferably dry. Here, when the sheet-like antibacterial material 10 of this embodiment is wet, examples of the impregnating liquid impregnated in the sheet-like antibacterial material 10 include water, water-containing alcohol, and surfactant.
[0055] また、本形態のシート状抗菌性材料 10は、積層型であってもよ!/ヽ。積層型のシート 状抗菌性材料 10の形態としては、例えば、図 2に示す形態が挙げられる。図 2は、積 層型のシート状抗菌性材料を示す断面図である。図 2に示す形態において、シート 状抗菌性材料 10は、第 1のシート状材料 10Aと、第 2のシート状材料 10Bとからなる 。そして、第 1のシート状材料 10Aは、第 1のシート状基材 12Aにヨウ素系化合物 (A ) 14のみが保持された構成を有する。一方、第 2のシート状材料 10Bは、第 2のシー ト状基材 12Bにヨウ素系酸化剤 (B) 16および酸化合物 (C) 18が保持された構成を 有する。  [0055] Further, the sheet-like antibacterial material 10 of the present embodiment may be a laminated type! / ヽ. Examples of the form of the laminated sheet-like antibacterial material 10 include the form shown in FIG. FIG. 2 is a cross-sectional view showing a laminated sheet-like antibacterial material. In the form shown in FIG. 2, the sheet-like antibacterial material 10 includes a first sheet-like material 10A and a second sheet-like material 10B. The first sheet-like material 10A has a configuration in which only the iodine compound (A) 14 is held on the first sheet-like substrate 12A. On the other hand, the second sheet-like material 10B has a configuration in which the iodine-based oxidizing agent (B) 16 and the acid compound (C) 18 are held on the second sheet-like base material 12B.
[0056] 図 2に示すように、ヨウ素系化合物 (A) 14とヨウ素系酸化剤(B) 16とが別々の固体 基材に保持されてなる積層型のシート状抗菌性材料 10は、使用前にはヨウ素色をほ とんど呈さないため、好ましい。さらに、製造工程において I  [0056] As shown in FIG. 2, the laminated sheet-like antibacterial material 10 in which the iodine compound (A) 14 and the iodine oxidant (B) 16 are held on separate solid substrates is used. It is preferable because it hardly exhibits iodine color before. In addition, I
3—や I  3—and I
5—が存在しないため Because 5— does not exist
、製造機器の腐蝕が防止されうるという観点からも好ましい。ただし、シート状抗菌性 材料 10の呈するヨウ素色が薄められた形態のみに、本発明の技術的範囲が制限さ れるわけではない。図 2に示す形態のシート状抗菌性材料 10の呈するヨウ素色が低 減される理由については、下記の製造方法の欄において、詳述する。また、図 2に示 すように、酸化合物 (C) 18がヨウ素系化合物 (A) 14とは別の固体基材に保持される と、換言すれば、ヨウ素系酸化剤 (B)が保持された固体基材に酸化合物 (C) 18が保 持されると、酸化合物 (C)の影響による、ヨウ素系化合物 (A)力ものヨウ素 (I—や I ") It is also preferable from the viewpoint that corrosion of manufacturing equipment can be prevented. However, the technical scope of the present invention is not limited only to the form in which the iodine color exhibited by the sheet-like antibacterial material 10 is thinned. The reason why the iodine color exhibited by the sheet-like antibacterial material 10 having the form shown in FIG. 2 is reduced will be described in detail in the column of the production method below. As shown in FIG. 2, when the acid compound (C) 18 is held on a solid substrate different from the iodine compound (A) 14, in other words, the iodine oxidant (B) is held. When the acid compound (C) 18 is held on the solid substrate, the iodine compound (A) power iodine (I— or I ") due to the influence of the acid compound (C)
3 5 の生成の可能性を完全に除去できると 、う観点力も好まし 、。  If we can completely eliminate the possibility of generating 3 5, we will also like the viewpoint power.
[0057] ここで、図 2に示す形態のシート状抗菌性材料 10を構成する各シート状材料(10A 、 10B)および各シート状材料の本体である各シート状基材(12A、 12B)に冠せられ る「第 1の」および「第 2の」という語は、ヨウ素系化合物 14と、ヨウ素系酸化剤 16およ び酸ィ匕合物 18とが、それぞれ別々のシート状基材に保持され、それぞれ別々のシー ト状材料を構成して ヽることを示すために便宜的に用いられて ヽるに過ぎな、ヽ。従つ て、「第 1の」および「第 2の」という序列自体に格別の意味はない。また、第 1のシート 状基材 12Aの原料と第 2のシート状基材 12Bの原料とは、同一であってもよいし、異 なっていてもよい。 Here, each sheet-like material (10A, 10B) constituting the sheet-like antibacterial material 10 having the form shown in FIG. 2 and each sheet-like substrate (12A, 12B) which is the main body of each sheet-like material are provided. Crowned The terms “first” and “second” mean that iodine-based compound 14, iodine-based oxidizing agent 16 and acid compound 18 are held on separate sheet-like substrates, respectively. It is only used for convenience to show that each sheet is composed of a separate sheet of material. Therefore, the “first” and “second” orders themselves have no special meaning. Further, the raw material of the first sheet-like base material 12A and the raw material of the second sheet-like base material 12B may be the same or different.
[0058] なお、本形態の抗菌性材料がシート状抗菌性材料である場合、各成分がシート状 基材に保持される形態は図 2に示す形態のみには限定されず、任意の形態が採用さ れうる。例えば、図 2に示す形態のほか、(1)ヨウ素系化合物 (A)およびヨウ素系酸ィ匕 剤 (B)が第 1のシート状基材に保持され、酸化合物 (C)が第 2のシート状基材に保持 される形態;(2)ヨウ素系化合物 (A)および酸化合物 (C)が第 1のシート状基材に保 持され、ヨウ素系酸化剤 (B)が第 2のシート状基材に保持される形態;(3)ヨウ素系化 合物 (A)が第 1のシート状基材に保持され、ヨウ素系酸化剤 (B)が第 2のシート状基 材に保持され、酸ィ匕合物 (C)が第 3のシート状基材に保持される (ただし、第 1〜第 3 のシート状基材の積層順序に制限はない)形態など、どのような形態も採用されうる。  [0058] When the antibacterial material of the present embodiment is a sheet-like antibacterial material, the form in which each component is held on the sheet-like base material is not limited to the form shown in FIG. Can be adopted. For example, in addition to the form shown in FIG. 2, (1) the iodine compound (A) and the iodine acid oxidizing agent (B) are held on the first sheet-like substrate, and the acid compound (C) is the second compound. Form held on the sheet-like substrate; (2) Iodine-based compound (A) and acid compound (C) are held on the first sheet-like substrate, and iodine-based oxidant (B) is the second sheet. (3) Iodine compound (A) is held on the first sheet-like substrate and iodine-based oxidant (B) is held on the second sheet-like substrate. In addition, any form such as a form in which the acid compound (C) is held on the third sheet-like substrate (however, the order of stacking the first to third sheet-like substrates is not limited) It can be adopted.
[0059] あるいは、本形態のシート状抗菌性材料 10は、図 1および図 2に示す形態のシート 状抗菌性材料 10の片面または両面に、本形態におけるシート状抗菌性材料以外の シートがさらに配置されてなる積層型シートであってもよい。上述したように、本形態 のシート状抗菌性材料は使用時にヨウ素色を呈する場合がある。かような場合に、他 のシートと積層された積層型シートとすることで、ヨウ素色を呈する本形態のシート状 抗菌性材料が被覆され、外観が改善されうる。カゝような積層型シートにおいても、積 層型シートの表面に付着した微生物を含む汚染物は本形態のシート状抗菌性材料 の層まで拡散しうるため、抗菌作用は充分に発揮されうる。また、図 2に示す形態の シート状抗菌性材料 10において、第 1のシート状材料 10Aと第 2のシート状材料 10 Bとの間に、本形態におけるシート状抗菌性材料や当該材料を構成するシート以外 のシートがさらに配置されてもよい。力 うな積層型シートにおいても、抗菌作用は充 分に発揮されうる。なお、本形態のシート状抗菌性材料が積層型シートとされる場合 、本形態のシート状抗菌性材料に加えて配置されうるシートとしては、特に制限され ないが、例えば、本形態において用いられうる基材カもなるシートが、採用されうる。 [0059] Alternatively, the sheet-like antibacterial material 10 of this embodiment is further provided with a sheet other than the sheet-like antibacterial material of this embodiment on one or both sides of the sheet-like antibacterial material 10 of the form shown in FIGS. It may be a laminated sheet formed. As described above, the sheet-like antibacterial material of this embodiment may exhibit an iodine color when used. In such a case, by forming a laminated sheet laminated with another sheet, the sheet-like antibacterial material of the present embodiment exhibiting iodine color can be coated and the appearance can be improved. Even in a laminated sheet such as a cocoon, the contaminants including microorganisms attached to the surface of the stacked sheet can diffuse to the layer of the sheet-like antibacterial material of this embodiment, so that the antibacterial action can be sufficiently exerted. Further, in the sheet-like antibacterial material 10 of the form shown in FIG. 2, the sheet-like antibacterial material and the material in this embodiment are configured between the first sheet-like material 10A and the second sheet-like material 10B. Sheets other than the sheet to be performed may be further arranged. Antibacterial action can be fully exerted even in powerful laminated sheets. When the sheet-like antibacterial material of this embodiment is a laminated sheet, the sheet that can be disposed in addition to the sheet-like antibacterial material of this embodiment is particularly limited. For example, a sheet that also serves as a base material that can be used in the present embodiment can be adopted.
[0060] 本形態のシート状抗菌性材料 10の製造方法については、特に制限はない。  [0060] The method for producing the sheet-like antibacterial material 10 of the present embodiment is not particularly limited.
[0061] 図 1に示す形態のシート状抗菌性材料 10は、例えば、保持させたい成分を含む浸 漬溶液を調製し、当該溶液にシート状基材 12を浸漬させ、取り出して乾燥させるとい う手法により、製造可能である。以下、工程順に説明する。 [0061] The sheet-like antibacterial material 10 having the form shown in FIG. 1 is prepared by, for example, preparing an immersion solution containing components to be retained, immersing the sheet-like base material 12 in the solution, taking out and drying it. It can be manufactured by a method. Hereinafter, it demonstrates in order of a process.
[0062] まず、適当な溶媒を準備し、準備した溶媒に、上述したヨウ素系化合物 (A) 14、ョ ゥ素系酸化剤 (B) 16、および酸化合物 (C) 18を添加することにより、浸漬溶液を調 製する。この際、上記の成分以外の成分をもシート状基材 12に保持させたい場合に は、保持させたい成分を同時に浸漬溶液に添加するとよい。また、従来公知の知見 に基づいて、これらの添加剤のほかにも、溶液の特性を変化させる目的で安定化剤 等のその他の添加剤が添加されてもよい。準備する溶媒については特に制限はなく 、水、エタノール、メタノール、トルエン、酢酸ェチル、アセトン、テトラヒドロフラン、ジメ チルスルホキシド、およびこれらの混合溶媒などが用いられうる。ただし、上記の各成 分を充分に溶解させうるという観点力 は、水または水を主成分とする溶媒が好ましく 用いられうる。 [0062] First, an appropriate solvent is prepared, and the above-mentioned iodine-based compound (A) 14, iodine-based oxidizing agent (B) 16, and acid compound (C) 18 are added to the prepared solvent. Prepare an immersion solution. At this time, when it is desired to hold components other than the above-mentioned components on the sheet-like base material 12, the components to be held may be added simultaneously to the dipping solution. In addition to these known additives, other additives such as stabilizers may be added for the purpose of changing the properties of the solution based on known knowledge. The solvent to be prepared is not particularly limited, and water, ethanol, methanol, toluene, ethyl acetate, acetone, tetrahydrofuran, dimethyl sulfoxide, and a mixed solvent thereof can be used. However, from the viewpoint of being able to sufficiently dissolve each of the above components, water or a solvent containing water as a main component can be preferably used.
[0063] 次いで、別途準備したシート状基材 12を、上記で調製した浸漬溶液に浸漬させる。  [0063] Next, the separately prepared sheet-like substrate 12 is immersed in the immersion solution prepared above.
これにより、浸漬溶液に含まれる各成分がシート状基材 12の内部および表面に保持 される。浸潰させる際の具体的な温度条件ゃ浸漬時間については特に制限はなぐ 従来公知の知見が適宜参照されうる。  Thereby, each component contained in the dipping solution is held inside and on the surface of the sheet-like substrate 12. There are no particular restrictions on the specific temperature conditions when soaking and soaking time. Conventionally known knowledge can be referred to as appropriate.
[0064] その後、浸漬溶液力もシート状基材 12を取り出し、乾燥させる。乾燥の具体的な手 法についても特に制限はなぐ自然乾燥が用いられてもよいし、加熱や送風による強 制乾燥が用いられてもよ 、。加熱時の温度条件や乾燥時間につ ヽても特に制限は なぐ従来公知の知見を参照して、適宜設定すればよい。  [0064] After that, the sheet-like base material 12 is taken out and dried with a dipping solution force. There are no particular restrictions on the specific drying method, natural drying may be used, or forced drying by heating or blowing may be used. There are no particular restrictions on the temperature conditions and the drying time during heating, and it may be set as appropriate with reference to known knowledge.
[0065] 以上、浸漬溶液に含まれる各成分を、浸漬法によりシート状基材 12の内部および 表面に保持させる形態を例に挙げて説明したが、本形態のシート状抗菌性材料 10 の製造方法力 Sかような形態のみに制限されるわけではない。例えば、上記で調製し た溶液をスプレー塗布やロール添着などの手法によりシート状基材 12の表面に塗布 するといつた手法が採用されてもよい。そして、塗布後に同様の乾燥処理を施せばよ い。力 うな形態によれば、溶液中の各成分がシート状基材 12の表面に保持された 形態のシート状抗菌性材料 10が製造されうる。さらに、可能であれば、上記の浸漬 溶液にさらにシート状基材 12の原料を添加し、抄紙するといつた手法が採用されても よい。 [0065] As described above, the description has been given by taking as an example the form in which each component contained in the dipping solution is held inside and on the surface of the sheet-like base material 12 by the dipping method, but the production of the sheet-like antibacterial material 10 of this embodiment is described. It is not limited to the form of method power S. For example, any method may be employed when the solution prepared above is applied to the surface of the sheet-like substrate 12 by a method such as spray coating or roll attachment. Then, after applying the same drying process Yes. According to the strong form, the sheet-like antibacterial material 10 in a form in which each component in the solution is held on the surface of the sheet-like substrate 12 can be produced. Further, if possible, a method may be adopted in which the raw material of the sheet-like substrate 12 is further added to the above immersion solution and paper is made.
[0066] 本発明のさらに他の形態によれば、上述したシート状抗菌性材料の好ましい製造 方法が提供される。本形態の製造方法によれば、図 2に示す形態のシート状抗菌性 材料が製造されうる。すなわち、本形態は、溶媒にヨウ素系化合物 (A)を溶解させた 溶液に、第 1のシート状基材を浸漬させて、前記第 1のシート状基材に前記ヨウ素系 化合物 (A)を保持させる工程と、溶媒にヨウ素系酸化剤 (B)および酸化合物 (C)を 溶解させた溶液に、第 2のシート状基材を浸漬させて、前記第 2のシート状基材に前 記ヨウ素系酸化剤 (B)および前記酸化合物 (C)を保持させる工程と、前記第 1のシ ート状基材および前記第 2のシート状基材を乾燥させる工程と、前記第 1のシート状 基材および前記第 2のシート状基材を積層する工程と、を有する、シート状抗菌性材 料の製造方法である。参考までに、本形態の製造方法により積層型のシート状抗菌 性材料を製造する様子を図 3に示す。  [0066] According to still another aspect of the present invention, a preferable method for producing the above-described sheet-like antibacterial material is provided. According to the manufacturing method of this embodiment, the sheet-like antibacterial material having the configuration shown in FIG. 2 can be manufactured. That is, in this embodiment, the first sheet-like substrate is immersed in a solution in which the iodine-based compound (A) is dissolved in a solvent, and the iodine-based compound (A) is added to the first sheet-like substrate. The step of holding, the second sheet-like substrate is immersed in a solution in which the iodine-based oxidizing agent (B) and the acid compound (C) are dissolved in a solvent, and the second sheet-like substrate is A step of retaining the iodine-based oxidizing agent (B) and the acid compound (C), a step of drying the first sheet-like substrate and the second sheet-like substrate, and the first sheet. And a step of laminating the second sheet-shaped substrate and the second sheet-shaped substrate. For reference, Figure 3 shows how a laminated sheet-like antibacterial material is manufactured by the manufacturing method of this embodiment.
[0067] 本形態の製造方法は、図 3に示すように、ヨウ素系化合物 (A)を含む浸漬溶液と、 ヨウ素系酸化剤 (B)および酸化合物 (C)を含む浸漬溶液とを別々に調製し、それぞ れに別々のシート状基材 12を浸漬させて各成分を保持させ、それぞれのシート状基 材 12を積層することによりシート状抗菌性材料 10とする点以外は、図 1に示す形態 のシート状抗菌性材料についての上記の製造方法と同様である。  [0067] As shown in Fig. 3, the production method of the present embodiment separately includes an immersion solution containing an iodine-based compound (A) and an immersion solution containing an iodine-based oxidizing agent (B) and an acid compound (C). Except for preparing the sheet-like antibacterial material 10 by laminating each sheet-like base material 12 by laminating each sheet-like base material 12 by immersing a separate sheet-like base material 12 in each of them, It is the same as that of said manufacturing method about the sheet-like antibacterial material of the form shown to.
[0068] 本形態の製造方法により製造される、図 2に示す形態のシート状抗菌性材料 10は 、上述したように、使用前にはヨウ素色をほとんど呈さない。これは、以下のように説 明される。  [0068] As described above, the sheet-like antibacterial material 10 of the form shown in FIG. 2 produced by the production method of the present embodiment exhibits almost no iodine color before use. This is explained as follows.
[0069] すなわち、保持される全ての成分を含む浸漬溶液を一度に調製すると、当該浸漬 溶液において、上記の化学反応式(1)〜(3)で示される反応が進行する。従って、あ る程度の I—や I 一、 Iが生成し、保持工程においてこれらも保持されることで、製造さ  [0069] That is, when an immersion solution containing all the components to be retained is prepared at a time, the reactions represented by the chemical reaction formulas (1) to (3) proceed in the immersion solution. Therefore, a certain amount of I—, I 1, and I are generated, and these are also retained in the retention process.
3 5 2  3 5 2
れるシート状抗菌性材料 10はある程度のヨウ素色を呈する。これに対し、本形態の 製造方法によれば、保持される各成分が浸漬溶液中に一度に共存することがないた め、ヨウ素色を呈する I—や I―、 Iが生成しない。このため、本形態の製造方法によつ The sheet-like antibacterial material 10 exhibits a certain iodine color. In contrast, according to the manufacturing method of the present embodiment, each component to be retained does not coexist in the immersion solution at a time. Therefore, I-, I-, and I showing iodine color are not generated. For this reason, the manufacturing method of this embodiment
3 5 2  3 5 2
て製造されるシート状抗菌性材料は使用前にヨウ素色を呈することはほとんどないの である。従って、本形態の製造方法によれば、美観上好ましいシート状抗菌性材料 1 0が製造されうる。さらに、製造工程において I—や I—が存在しないため、製造機器  The sheet-like antibacterial material produced in this way rarely shows an iodine color before use. Therefore, according to the manufacturing method of the present embodiment, an aesthetically preferable sheet-like antibacterial material 10 can be manufactured. Furthermore, since there is no I- or I- in the manufacturing process,
3 5  3 5
の腐蝕が防止されうると 、う観点からも好ま 、。  From the standpoint of being able to prevent the corrosion of the.
[0070] 本形態の製造方法においては、第 1のシート状基材 12Aおよび第 2のシート状基 材 12Bのそれぞれに所望の成分を保持させた後、これを積層して、積層型のシート 状抗菌性材料 10とする。この際、各シート状基材 12を各浸漬溶液力も取り出した後 、乾燥前に積層し、積層後に乾燥させてもよいし、各シート状基材 12を各浸漬溶液 から取り出した後、それぞれのシート状基材 12を乾燥させて、乾燥後に積層してもよ い。上述のメカニズムにより I—や I―、 Iを生成させないという観点からは、乾燥後に [0070] In the manufacturing method of the present embodiment, each of the first sheet-like base material 12A and the second sheet-like base material 12B is made to hold desired components and then laminated to form a laminated sheet. Antimicrobial material 10 At this time, after each sheet-like substrate 12 is also taken out of each immersion solution force, it may be laminated before drying, and dried after lamination, or each sheet-like substrate 12 may be taken out from each immersion solution, and then each The sheet-like substrate 12 may be dried and laminated after drying. From the point of view that I-, I-, and I are not generated by the mechanism described above,
3 5 2  3 5 2
積層する形態が好ましく採用されうる。  A laminated form can be preferably adopted.
[0071] 各シート状基材 12を積層することにより積層型のシートとする際の積層の手法は特 に制限されず、積層シートの製造分野において従来公知の手法が適宜採用されうる 。積層手法の選択にあたっては、第 1のシート状基材 12Aに保持された成分と、第 2 のシート状基材 12Bに保持された成分とが積層時にはほとんど反応しないように考 慮するとよい。積層手法の一例としては、例えば、第 1のシート状基材 12Aと第 2のシ 一ト状基材とを重ねて積層体とし、当該積層体の周辺部のみを熱接着する手法が挙 げられる。その他の手法が採用されても、勿論よい。  [0071] The method of laminating when the sheet-like base materials 12 are laminated to form a laminated sheet is not particularly limited, and conventionally known methods can be appropriately employed in the field of producing laminated sheets. In selecting the lamination method, it is preferable to consider that the component held on the first sheet-like substrate 12A and the component held on the second sheet-like substrate 12B hardly react at the time of lamination. As an example of the laminating method, for example, there is a method in which the first sheet-like substrate 12A and the second sheet-like substrate are laminated to form a laminated body, and only the peripheral part of the laminated body is thermally bonded. It is done. Of course, other methods may be adopted.
[0072] 本形態のシート状抗菌性材料 10は、各成分の保持量や固体基材などの形態が適 宜調節されることによって、種々の用途に適用されうる。例えば、微生物を含む汚染 物が付着しうる区画において本形態のシート状抗菌性材料 10を用いることで、汚染 物が本形態のシート状抗菌性材料 10に付着し、付着した汚染物中の水分との接触 によって生成したヨウ素イオン (Γ)、ヨウ素系酸化剤 (IO_、 IO一、 IO―)、およびプロ  [0072] The sheet-like antibacterial material 10 of the present embodiment can be applied to various uses by appropriately adjusting the amount of each component retained and the form of a solid substrate. For example, by using the sheet-shaped antibacterial material 10 of this embodiment in a compartment to which contaminants including microorganisms can adhere, the contaminant adheres to the sheet-shaped antibacterial material 10 of this embodiment, and moisture in the adhered contaminants. Iodine ions (Γ) generated by contact with iodine, iodine-based oxidants (IO_, IO-I, IO-), and
3 4  3 4
トン (H+)から、上述の化学反応式(1)〜(3)に示すメカニズムによって I—や I—が生  Ton (H +) produces I- and I- by the mechanism shown in the chemical reaction formulas (1) to (3) above.
3 5 成し、これらによって含まれる微生物が効果的に殺菌されうる。すなわち、抗菌作用 が発現する。  Therefore, the microorganisms contained therein can be effectively sterilized. That is, an antibacterial action is exhibited.
[0073] よって、本形態のシート状抗菌性材料 10の具体的な用途としては、例えば、トイレ 用マットとしてトイレの床に敷く;実験台シートとして微生物を取扱う研究施設にぉ ヽ て実験台や床の上に敷く;医療用シートとして医療機関における作業台や床の上に 敷く;ペット用シートとしてペット用トイレや鳥かごの中に敷く;キッチンペーパーとして キッチンの作業台や床の上に敷くといった敷物用、浸漬殺菌シートとして微生物によ り汚染された溶液に浸漬させるといった浸漬用、フィルタとして、エアコン、空気清浄 器および掃除機に装着されるといったフィルタ用などの形態が挙げられるが、これら に制限されるわけではない。また、上記のような種々の場所において、汚染物を拭き 取るための拭き取り用に用いられても、勿論よい。 Therefore, a specific application of the sheet-like antibacterial material 10 of the present embodiment is, for example, a toilet Laid on the floor of the toilet as a laboratory mat; laid on a laboratory table or floor as a laboratory table, and placed on a laboratory table or floor; laid on a work table or floor in a medical institution as a medical sheet; As a kitchen paper, for rugs such as laying on a kitchen workbench or floor, as a soaking sterilization sheet, for soaking in a solution contaminated by microorganisms, as a filter, Examples include filters for air conditioners, air cleaners, and vacuum cleaners, but are not limited to these. Of course, it may be used for wiping off contaminants in various places as described above.
[0074] (第 3実施形態)  [0074] (Third embodiment)
以上、固体基材としてシート状基材を用いたシート状抗菌性材料を例に挙げて本 発明の抗菌性材料の構成およびその製造方法を詳細に説明したが、本発明の技術 的範囲は特許請求の範囲の記載に基づいて定められるべきであり、シート状の形態 のみに制限されるわけではない。  As described above, the configuration of the antibacterial material of the present invention and the manufacturing method thereof have been described in detail by taking as an example a sheet-like antibacterial material using a sheet-like base material as a solid substrate. It should be determined based on the description of the scope of claims, and is not limited to the sheet form.
[0075] 本形態の抗菌性材料のシート状以外の形態としては、例えば、固体基材として粒状 基材が用いられた粒状の形態が挙げられる。すなわち、本願は、固体基材が粒状基 材である抗菌性材料をも提供する。 [0075] Examples of forms other than the sheet form of the antibacterial material of the present embodiment include a granular form in which a granular base material is used as a solid base material. That is, the present application also provides an antibacterial material whose solid substrate is a granular substrate.
[0076] 本形態の抗菌性材料は、固体基材の形状が粒状であること以外は上述したシート 状抗菌性材料と同様である。従って、ここでは詳細な説明を省略する。 [0076] The antibacterial material of the present embodiment is the same as the above-described sheet-like antibacterial material except that the solid substrate has a granular shape. Therefore, detailed description is omitted here.
[0077] 粒状基材の粒径は特に制限されず、粒状抗菌性材料の用途に応じて適宜決定さ れうる。 [0077] The particle size of the granular substrate is not particularly limited, and can be appropriately determined according to the use of the granular antibacterial material.
[0078] 本形態の抗菌性材料においては、第 1実施形態の欄において説明した各成分が 粒状基材に含まれる。この際、各成分の含有形態について特に制限はない。例えば 、ヨウ素系化合物 (A)、ヨウ素系酸化剤 (B)、および酸ィ匕合物 (C)の全てが同一の粒 状基材に保持されてなる形態であってもよい。この形態は、概念的には図 1に示す形 態のシート状抗菌性材料に対応する。また、本形態の粒状抗菌性材料は、第 1の粒 状基材に、ヨウ素系化合物 (A)が保持されてなる第 1の粒状材料と、第 2の粒状基材 に、ヨウ素系酸化剤 (B)および酸ィ匕合物 (C)が保持されてなる第 2の粒状材料と、が 混合されてなる混合型の形態であってもよい。この形態は、概念的には図 2に示す積 層型のシート状抗菌性材料に対応する。ただし、これらの形態のみには制限されず、 例えば、(1)ヨウ素系化合物 (A)およびヨウ素系酸化剤 (B)が第 1の粒状基材に保持 され、酸化合物 (C)が第 2の粒状基材に保持される形態;(2)ヨウ素系化合物 (A)お よび酸化合物 (C)が第 1の粒状基材に保持され、ヨウ素系酸化剤 (B)が第 2の粒状 基材に保持される形態;(3)ヨウ素系化合物 (A)が第 1の粒状基材に保持され、ヨウ 素系酸化剤 (B)が第 2の粒状基材に保持され、酸化合物 (C)が第 3の粒状基材に保 持され、これらの粒状基材が均質に混合されてなる形態など、どのような形態も採用 されうる。 [0078] In the antibacterial material of the present embodiment, each component described in the column of the first embodiment is included in the granular base material. At this time, there are no particular limitations on the form of each component. For example, the iodine compound (A), the iodine oxidant (B), and the acid compound (C) may all be held on the same granular base material. This form conceptually corresponds to the sheet-like antibacterial material shown in FIG. In addition, the particulate antibacterial material of the present embodiment includes a first particulate material in which the iodine compound (A) is held on the first particulate substrate, and an iodine oxidant on the second particulate substrate. It may be in the form of a mixed type obtained by mixing (B) and the second granular material in which the acid compound (C) is held. This form is conceptually the product shown in Figure 2. Corresponds to a layered sheet-like antibacterial material. However, the present invention is not limited to these forms. For example, (1) iodine compound (A) and iodine oxidant (B) are held on the first granular base material, and acid compound (C) is the second. (2) The iodine compound (A) and the acid compound (C) are held on the first granular substrate, and the iodine oxidant (B) is the second granular substrate. (3) Iodine compound (A) is held on the first granular substrate, iodine oxidant (B) is held on the second granular substrate, and acid compound (C ) Is held on the third granular base material, and any form can be adopted such as a form in which these granular base materials are mixed homogeneously.
[0079] 粒状基材の形状やサイズについても特に制限はない。粒状基材の形状は球状で あってもよいし、直方体状や不定形状であってもよい。また、サイズについても、粒状 と称される程度に小さ 、もののほか、塊状や固形物と 、つた印象を与えうる大き 、も のもまた、粒状基材として用いられうる。  [0079] The shape and size of the granular substrate are not particularly limited. The shape of the granular base material may be spherical, or a rectangular parallelepiped shape or an indefinite shape. Also, the size is small enough to be referred to as granular, and in addition to lumps and solids, large sizes that can give an impression can also be used as granular substrates.
[0080] 本形態の抗菌性材料の製造方法についても特に制限はない。上述した第 2実施形 態の抗菌性材料の製造方法にお!ヽて、用いる固体基材をシート状基材から粒状基 材に代えることで、本形態の粒状抗菌性材料が製造可能である。また、上述した第 2 実施形態の抗菌性材料の製造方法と同様の思想によって、第 1の粒状基材にヨウ素 系化合物 (A)を保持させ、第 2の粒状基材にヨウ素系酸化剤 (B)および酸化合物 (C )を保持させ、そして各成分が保持された第 1の粒状基材と第 2の粒状基材とを混合 することによって、混合型の粒状抗菌性材料が製造されうる。  [0080] The method for producing the antibacterial material of this embodiment is not particularly limited. In the manufacturing method of the antibacterial material of the second embodiment described above! The granular antibacterial material of this embodiment can be manufactured by replacing the solid substrate to be used from a sheet-like substrate with a granular substrate. Further, the iodine compound (A) is held on the first granular substrate and the iodine-based oxidant (on the second granular substrate) according to the same idea as the method of manufacturing the antibacterial material of the second embodiment described above. A mixed granular antibacterial material can be produced by retaining the B) and the acid compound (C) and mixing the first granular substrate and the second granular substrate in which the respective components are retained. .
[0081] 粒状である本形態の抗菌性材料は、各成分の含有量や固体基材などの形態が適 宜調節されることで、シート状抗菌性材料と同様のメカニズムによって種々の用途に 適用され、抗菌性を発揮しうる。そしてその際には、ヨウ素が有効に利用されうる。  [0081] The antibacterial material of this form which is granular can be applied to various uses by the same mechanism as the sheet-like antibacterial material by appropriately adjusting the content of each component and the form of the solid substrate. And can exhibit antibacterial properties. In this case, iodine can be used effectively.
[0082] 粒状である本形態の抗菌性材料の具体的な用途としては、例えば、ペット用トイレ 砂としてペット用トイレの底に敷くといった敷物用;布団用もしくは枕用充填材として布 団ゃ枕の内部に充填するといつた充填用などの形態が挙げられるが、これらに制限 されるわけではない。  [0082] Specific uses of the antibacterial material of the present embodiment which is granular include, for example, for rugs such as pet toilet sand laid on the bottom of pet toilets; When filling the inside of the container, there are forms for filling, etc., but it is not limited to these.
実施例  Example
[0083] 以下、実施例を用いて本発明をより詳細に説明するが、本発明の技術的範囲が下 記の形態のみに制限されるわけではな 、。 [0083] Hereinafter, the present invention will be described in more detail with reference to examples. However, the technical scope of the present invention is below. It is not limited to the form described above.
[0084] <実施例 1 >  <Example 1>
水にヨウ素系化合物 (A)であるヨウ化カリウム (KI) (0. 109質量%)、ヨウ素系酸ィ匕 剤(B)であるヨウ素酸カリウム (KIO ) ( 1. 0質量0 /0)、酸ィ匕合物(C)であるクェン酸一 Water iodine compound potassium iodide is (A) (KI) (0. 109 mass%), potassium iodate is iodine Sani匕agent (B) (KIO) (1. 0 mass 0/0) , Acid compound (C)
3  Three
水和物(2. 0質量0 /0)、シクロデキストリン(CD)である a— CD (3. 0質量0 /0)およびメ チル β - CD (2. 0質量0 /0)を添加し、撹拌により溶解させた水溶液 lOOmLを準備し た。 Hydrate (2.0 mass 0/0), a cyclodextrin (CD) a- CD (3. 0 mass 0/0) and methylation beta - added CD (2.0 mass 0/0) Then, lOOmL of an aqueous solution dissolved by stirring was prepared.
[0085] 上記で準備した水溶液に、 1質量%デンプン試液 10mLを添カ卩し、ヨウ素—デンプ ン反応による青色液を得た。  [0085] To the aqueous solution prepared above, 10 mL of a 1% by mass starch test solution was added to obtain a blue liquid by iodine-denpene reaction.
[0086] この青色液に、 0. 02Nチォ硫酸ナトリウム液を撹拌しながら滴下していくと、ヨウ素 の還元により青色が消失したが、チォ硫酸ナトリウム液の滴下を中止して撹拌を継続 すると、初期と同等の青色が復活した。さらに、再度上記のチォ硫酸ナトリウム液を撹 拌しながら滴下していくと、ヨウ素の還元により青色が消失した力 チォ硫酸ナトリウム 液の滴下を中止して撹拌を継続すると、再度初期と同等の青色が復活した。  [0086] When 0.02N sodium thiosulfate solution was added dropwise to this blue liquid while stirring, the blue color disappeared due to the reduction of iodine, but when the addition of sodium thiosulfate liquid was stopped and stirring was continued, The blue color equivalent to the initial level has been restored. Furthermore, when the above sodium thiosulfate solution was added dropwise while stirring again, the blue color disappeared due to the reduction of iodine. Was revived.
[0087] 以上のことから、本実施例の水溶液においては、水溶液中に存在するヨウ化物ィォ ン (Γ)が絶えずヨウ素 (I—や I―)に再生されていることが示唆される。  From the above, it is suggested that in the aqueous solution of this example, iodide ion (Γ) present in the aqueous solution is constantly regenerated into iodine (I— and I—).
3 5  3 5
[0088] <実施例 2 >  <Example 2>
以下の手法により、図 3に示す製造方法に従って、図 2に示す積層型のシート状抗 菌性材料を作製した。  The laminated sheet-like antibacterial material shown in FIG. 2 was produced by the following method according to the production method shown in FIG.
[0089] [浸漬溶液の調製] [0089] [Preparation of immersion solution]
まず、第 1の浸漬溶液の溶媒として、水を準備した。この水に、ヨウ素系化合物 (A) であるヨウ化カリウム (KI) (0. 109質量0 /0)、並びに、シクロデキストリン(CD)である a—CD (3. 0質量0 /0)およびメチルー β—CD (2. 0質量0 /0)を添カ卩し、撹拌により 均一に混合して、第 1の浸漬溶液を調製した。 First, water was prepared as a solvent for the first immersion solution. This water, iodine compounds potassium iodide is (A) (KI) (0. 109 mass 0/0), as well as, a-CD (3. 0 mass 0/0) cyclodextrin (CD) and and添Ka卩the methyl-beta-CD (2. 0 mass 0/0), and uniformly mixed by stirring to prepare a first dip solution.
[0090] 一方、第 2の浸漬溶液の溶媒として、上記と同様の水を準備した。この水に、ヨウ素 系酸化剤(B)であるヨウ素酸カリウム (KIO ) ( 1. 0質量0 /0)、酸ィ匕合物(C)であるク On the other hand, water similar to the above was prepared as a solvent for the second immersion solution. This water, potassium iodate is iodine based oxidizing agent (B) (KIO) (1. 0 mass 0/0), a Sani匕合product (C) click
3  Three
ェン酸一水和物(2. 0質量%)、および上記と同様のメチルー β CD (5. 0質量%) を添加し、撹拌により均一に混合して、第 2の浸漬溶液を調製した。 [0091] さらに、固体基材として、市販のパルプ製織布 (株式会社サン'ジャパン製;「ぺー パー化学ぞうきん 厚手」)を 5cm X 5cmのサイズに計 2枚切断して、第 1および第 2 のシート状基材を準備した。 A second immersion solution was prepared by adding citric acid monohydrate (2.0% by mass) and methyl-β CD (5.0% by mass) as described above, and mixing uniformly by stirring. . [0091] Furthermore, as a solid base material, a commercially available pulp woven fabric (manufactured by Sun 'Japan Co., Ltd .; "Paper Chemical Thick Skin Thick") was cut into a total size of 5 cm x 5 cm, and the first and first 2 sheet-like base materials were prepared.
[0092] 上記で調製した第 1および第 2の浸漬溶液に、上記で準備した第 1および第 2のシ ート状基材をそれぞれ浸漬させ、 25°Cにて 1分間放置し、浸漬溶液中の各成分をシ ート状基材に保持させた。 [0092] The first and second sheet-like base materials prepared above are immersed in the first and second immersion solutions prepared above, respectively, and left at 25 ° C for 1 minute. Each component therein was held on a sheet-like substrate.
[0093] 次 、で、各浸漬溶液から各シート状基材を取り出し、これらを乾燥機による 80°Cの 熱風に 30分間当て、各シート状基材を乾燥させた。 [0093] Next, each sheet-like substrate was taken out from each dipping solution, and these were applied to hot air at 80 ° C for 30 minutes by a dryer to dry each sheet-like substrate.
[0094] そして、各シート状基材を積層した後に積層体をクリップで固定して、本実施例の 抗菌性シートを作製した。 [0094] Then, after laminating the respective sheet-like base materials, the laminate was fixed with clips to produce the antibacterial sheet of this example.
[0095] 作製した抗菌性シートの中央部に、 1質量%デンプン水溶液を滴下したところ、滴 下部位が鮮やかな青紫色を呈し、いわゆるヨウ素 デンプン反応が進行していること が確認された。このヨウ素 デンプン反応による呈色は短時間では消失せず、数時 間程度維持された。 [0095] When a 1% by weight starch aqueous solution was dropped onto the center of the produced antibacterial sheet, it was confirmed that the dripping site had a bright blue-purple color and the so-called iodine starch reaction was progressing. The coloration due to the iodine-starch reaction did not disappear in a short time and was maintained for several hours.
[0096] <実施例 3 > <Example 3>
市販のティシュー (エリエール (登録商標)、大王製紙株式会社製)を 1枚ずつに剥 離後、 3cm X 3cmのサイズに切断し、水に浸漬させて取り出し、指先で麦粒大に丸 めて水を切った。次いで、赤外吸収スペクトル測定用 KBr打錠機を用いて 300kgの 圧力にて加圧して固化させて、粒状の固体基材を得た。そして、得られた固化物を 2 つの群に分けて、自然乾燥させた。  Peel off commercially available tissue (Erière (registered trademark), manufactured by Daio Paper Co., Ltd.) one by one, cut it into 3cm x 3cm size, take it out by immersing it in water, round it up to the size of wheat with your fingertips I drained the water. Subsequently, using a KBr tableting machine for infrared absorption spectrum measurement, the mixture was pressurized and solidified at a pressure of 300 kg to obtain a granular solid substrate. The resulting solidified product was divided into two groups and allowed to dry naturally.
[0097] その後、一方の群には上記の実施例 1で調製した第 1の浸漬溶液を滴下し、他方 の群には上記の実施例 1で調製した第 2の浸漬溶液を滴下して、浸漬溶液中の各成 分を固体基材に保持させた。  [0097] Thereafter, the first immersion solution prepared in Example 1 above was dropped into one group, and the second immersion solution prepared in Example 1 was dropped into the other group, Each component in the dipping solution was held on a solid substrate.
[0098] 次いで、各成分を保持させた固体基材を、 80°Cの熱風に 1時間当てることにより乾 燥させ、 2つの群の固体基材を均一に混和して、粒状の抗菌性材料を作製した。  [0098] Next, the solid base material holding each component was dried by applying hot air at 80 ° C for 1 hour, and the two groups of solid base materials were uniformly mixed to form a granular antibacterial material. Was made.
[0099] 作製した粒状の抗菌性材料に、 1質量%デンプン水溶液を滴下したところ、滴下部 位が鮮やかな青紫色を呈し、いわゆるヨウ素 デンプン反応が進行していることが確 認された。このヨウ素 デンプン反応による呈色は短時間では消失せず、数時間程 度維持された。 [0099] When a 1% by mass starch aqueous solution was dropped onto the produced granular antibacterial material, it was confirmed that the dropping portion had a bright blue-purple color and the so-called iodine starch reaction was progressing. This iodine-starch reaction does not disappear in a short time, and it takes several hours. Degrees were maintained.
[0100] 以上のことから、実施例 1のシート状の抗菌性材料および実施例 2の粒状の抗菌性 材料の双方において、水分との接触により I—や I—が生成し、さらにヨウ素の作用が  [0100] From the above, in both the sheet-like antibacterial material of Example 1 and the granular antibacterial material of Example 2, I— and I— are produced by contact with moisture, and the action of iodine But
3 5  3 5
長時間維持されうることが示された。従って、本発明の抗菌性材料は、汚染物と接触 した際にも抗菌作用を発揮しうることが示唆される。  It has been shown that it can be maintained for a long time. Therefore, it is suggested that the antibacterial material of the present invention can exert an antibacterial action even when it comes into contact with contaminants.
[0101] なお、本出願は、 2005年 5月 19日に出願された日本特許出願第 2005— 14697 2号に基づいており、その開示内容は、参照により全体として引用されている。 [0101] This application is based on Japanese Patent Application No. 2005-146972 filed on May 19, 2005, the disclosure of which is incorporated by reference in its entirety.

Claims

請求の範囲 The scope of the claims
[I] ヨウ素系化合物 (A)と、ヨウ素系酸化剤 (B)と、酸化合物 (C)と、を含み、前記ヨウ 素系化合物 (A)と前記ヨウ素系酸化剤 (B)との含有量の質量比が (B) Z (A) = 1〜 1000である、抗菌性組成物。  [I] An iodine compound (A), an iodine oxidant (B), and an acid compound (C), and containing the iodine compound (A) and the iodine oxidant (B) The antibacterial composition whose mass ratio of quantity is (B) Z (A) = 1-1000.
[2] 前記ヨウ素系化合物 (A)の含有量が、組成物の全量に対して 0. 001〜: L0質量% である、請求項 1に記載の抗菌性組成物。  [2] The antibacterial composition according to claim 1, wherein the content of the iodine compound (A) is 0.001 to L0% by mass with respect to the total amount of the composition.
[3] 前記ヨウ素系化合物 (A)がヨウ化物塩である、請求項 1または 2に記載の抗菌性組 成物。 [3] The antibacterial composition according to claim 1 or 2, wherein the iodine compound (A) is an iodide salt.
[4] 前記ヨウ素系酸化剤 (Β)が、次亜ヨウ素酸塩、ヨウ素酸塩、または過ヨウ素酸塩であ る、請求項 1〜3のいずれか 1項に記載の抗菌性組成物。  [4] The antibacterial composition according to any one of claims 1 to 3, wherein the iodine-based oxidizing agent (Β) is hypoiodite, iodate, or periodate.
[5] ヨウ素と複合体を形成しうる化合物をさらに含む、請求項 1〜4のいずれか 1項に記 載の抗菌性組成物。 [5] The antibacterial composition according to any one of claims 1 to 4, further comprising a compound capable of forming a complex with iodine.
[6] 前記ヨウ素と複合体を形成しうる化合物がシクロデキストリンである、請求項 5に記載 の抗菌性組成物。  6. The antibacterial composition according to claim 5, wherein the compound capable of forming a complex with iodine is cyclodextrin.
[7] 前記シクロデキストリンが、ヨウ素を包接してなるシクロデキストリン—ヨウ素包接ィ匕合 物の形態で含まれる、請求項 6に記載の抗菌性組成物。  7. The antibacterial composition according to claim 6, wherein the cyclodextrin is contained in the form of a cyclodextrin-iodine inclusion complex formed by inclusion of iodine.
[8] 水をさらに含む、請求項 1〜7のいずれか 1項に記載の抗菌性組成物。 [8] The antibacterial composition according to any one of claims 1 to 7, further comprising water.
[9] 固体基材と、 [9] a solid substrate;
前記固体基材の内部または表面に保持された、ヨウ素系化合物 (Α)、ヨウ素系酸 ィ匕剤 (Β)、および酸化合物 (C)と、  An iodine compound (Α), an iodine acid soot agent (Β), and an acid compound (C) held inside or on the surface of the solid substrate;
を含み、前記ヨウ素系化合物 (Α)と前記ヨウ素系酸化剤 (Β)との含有量の質量比が( Β) / (Α) = 1〜: L000である、抗菌性材料。  An antibacterial material, wherein the mass ratio of the content of the iodine compound (Α) and the iodine oxidant (Β) is (Β) / (Α) = 1 to L000.
[10] 前記ヨウ素系化合物 (Α)の含有量が、抗菌性材料の全量に対して 0. 00001-20 質量%である、請求項 9に記載の抗菌性材料。 10. The antibacterial material according to claim 9, wherein the content of the iodine compound (系) is 0.00001-20 mass% with respect to the total amount of the antibacterial material.
[II] 前記ヨウ素系化合物 (Α)がヨウ化物塩である、請求項 9または 10に記載の抗菌性 材料。  [II] The antibacterial material according to claim 9 or 10, wherein the iodine compound (化合物) is an iodide salt.
[12] 前記ヨウ素系酸化剤 (Β)が、次亜ヨウ素酸塩、ヨウ素酸塩、または過ヨウ素酸塩であ る、請求項 9〜11の 、ずれか 1項に記載の抗菌性材料。 [12] The antibacterial material according to any one of claims 9 to 11, wherein the iodine-based oxidizing agent (Β) is hypoiodite, iodate, or periodate.
[13] ヨウ素と複合体を形成しうる化合物が、前記固体基材にさらに保持されてなる、請求 項 9〜 12のいずれか 1項に記載の抗菌性材料。 [13] The antibacterial material according to any one of [9] to [12], wherein a compound capable of forming a complex with iodine is further retained on the solid substrate.
[14] 前記ヨウ素と複合体を形成しうる化合物がシクロデキストリンである、請求項 13に記 載の抗菌性材料。 14. The antibacterial material according to claim 13, wherein the compound capable of forming a complex with iodine is cyclodextrin.
[15] 前記シクロデキストリンが、ヨウ素を包接してなるシクロデキストリン一ヨウ素包接ィ匕合 物の形態で前記固体基材に保持されてなる、請求項 14に記載の抗菌性材料。  15. The antibacterial material according to claim 14, wherein the cyclodextrin is held on the solid base material in the form of a cyclodextrin / iodine inclusion complex formed by inclusion of iodine.
[16] 前記固体基材を構成する材料が、紙、織布、または不織布である、請求項 9〜15 の!、ずれか 1項に記載の抗菌性材料。 [16] The material according to claim 9-15, wherein the material constituting the solid substrate is paper, woven fabric, or non-woven fabric! The antibacterial material according to item 1.
[17] 前記固体基材がシート状基材または粒状基材である、請求項 9〜16のいずれか 1 項に記載の抗菌性材料。 [17] The antibacterial material according to any one of claims 9 to 16, wherein the solid substrate is a sheet-like substrate or a granular substrate.
[18] 前記ヨウ素系化合物 (A)と前記ヨウ素系酸化剤 (B)とが、別々の固体基材に保持さ れてなる、請求項 9〜17のいずれか 1項に記載の抗菌性材料。 [18] The antibacterial material according to any one of claims 9 to 17, wherein the iodine compound (A) and the iodine oxidant (B) are held on separate solid substrates. .
[19] 前記酸化合物 (C)が、前記ヨウ素系酸化剤 (B)が保持された固体基材に保持され てなる、請求項 9〜18のいずれか 1項に記載の抗菌性材料。 [19] The antibacterial material according to any one of [9] to [18], wherein the acid compound (C) is held on a solid substrate on which the iodine-based oxidizing agent (B) is held.
[20] 第 1のシート状基材に、前記ヨウ素系化合物 (A)が保持されてなる、第 1のシート状 材料と、 [20] a first sheet-like material in which the iodine-based compound (A) is held on a first sheet-like substrate;
第 2のシート状基材に、前記ヨウ素系酸化剤 (B)および前記酸化合物 (C)が保持さ れてなる、第 2のシート状材料と、  A second sheet-like material in which the iodine-based oxidizing agent (B) and the acid compound (C) are held on a second sheet-like substrate;
が積層されてなる、請求項 19に記載の抗菌性材料。  20. The antibacterial material according to claim 19, which is laminated.
[21] 第 1の粒状基材に、前記ヨウ素系化合物 (A)が保持されてなる、第 1の粒状材料と 第 2の粒状基材に、前記ヨウ素系酸化剤 (B)および前記酸化合物 (C)が保持され てなる、第 2の粒状材料と、 [21] The iodine-based oxidizing agent (B) and the acid compound are provided on the first granular material and the second granular substrate, wherein the iodine-based compound (A) is held on the first granular substrate. A second granular material in which (C) is retained;
が混合されてなる、請求項 19に記載の抗菌性材料。  20. The antibacterial material according to claim 19, which is mixed.
[22] 請求項 1〜8のいずれか 1項に記載の抗菌性組成物、または請求項 9〜21のいず れか 1項に記載の抗菌性材料を含む、敷物用、浸漬用、フィルタ用、拭き取り用、噴 霧用、または充填用の抗菌剤。 [22] An antibacterial composition according to any one of claims 1 to 8, or an antibacterial material according to any one of claims 9 to 21, for a rug, for dipping, and a filter. Antibacterial agent for wiping, wiping, spraying or filling.
[23] 溶媒にヨウ素系化合物 (A)を溶解させた溶液に、第 1のシート状基材を浸漬させて 、前記第 1のシート状基材に前記ヨウ素系化合物 (A)を保持させる工程と、 溶媒にヨウ素系酸化剤 (B)および酸化合物 (C)を溶解させた溶液に、第 2のシート 状基材を浸潰させて、前記第 2のシート状基材に前記ヨウ素系酸化剤 (B)および前 記酸化合物 (C)を保持させる工程と、 [23] The first sheet-like substrate is immersed in a solution in which the iodine compound (A) is dissolved in a solvent. A step of holding the iodine-based compound (A) on the first sheet-shaped substrate, and a solution in which the iodine-based oxidizing agent (B) and the acid compound (C) are dissolved in a solvent. A step of pulverizing the base material to hold the iodine-based oxidizing agent (B) and the acid compound (C) on the second sheet-like base material;
前記第 1のシート状基材および前記第 2のシート状基材を乾燥させる工程と、 前記第 1のシート状基材および前記第 2のシート状基材を積層する工程と、 を有する、シート状抗菌性材料の製造方法。  A step of drying the first sheet-like substrate and the second sheet-like substrate, and a step of laminating the first sheet-like substrate and the second sheet-like substrate. Method for producing antibacterial material.
溶媒にヨウ素系化合物 (A)を溶解させた溶液に、第 1の粒状基材を浸漬させて、前 記第 1の粒状基材に前記ヨウ素系化合物 (A)を保持させる工程と、  Immersing the first granular substrate in a solution in which the iodine compound (A) is dissolved in a solvent, and retaining the iodine compound (A) on the first granular substrate;
溶媒にヨウ素系酸化剤 (B)および酸化合物 (C)を溶解させた溶液に、第 2の粒状 基材を浸漬させて、前記第 2の粒状基材に前記ヨウ素系酸化剤 (B)および前記酸化 合物 (C)を保持させる工程と、  The second granular substrate is immersed in a solution in which the iodine-based oxidizing agent (B) and the acid compound (C) are dissolved in a solvent, and the iodine-based oxidizing agent (B) and the second granular substrate are immersed in the second granular substrate. Holding the oxide (C);
前記第 1の粒状基材および前記第 2の粒状基材を乾燥させる工程と、  Drying the first granular substrate and the second granular substrate;
前記第 1の粒状基材および前記第 2の粒状基材を混合する工程と、  Mixing the first granular substrate and the second granular substrate;
を有する、粒状抗菌性材料の製造方法。 A method for producing a granular antibacterial material.
PCT/JP2006/310048 2005-05-19 2006-05-19 Anti-bacterial composition and anti-bacterial material WO2006123784A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN2006800171526A CN101175405B (en) 2005-05-19 2006-05-19 Anti-bacterial composition and anti-bacterial material
JP2007516353A JPWO2006123784A1 (en) 2005-05-19 2006-05-19 Antibacterial composition and antibacterial material

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005-146972 2005-05-19
JP2005146972 2005-05-19

Publications (1)

Publication Number Publication Date
WO2006123784A1 true WO2006123784A1 (en) 2006-11-23

Family

ID=37431353

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/310048 WO2006123784A1 (en) 2005-05-19 2006-05-19 Anti-bacterial composition and anti-bacterial material

Country Status (4)

Country Link
JP (1) JPWO2006123784A1 (en)
CN (1) CN101175405B (en)
TW (1) TW200640369A (en)
WO (1) WO2006123784A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2366554A2 (en) 2010-03-16 2011-09-21 Ricoh Company, Ltd. Thermosensitive recording medium
JP6904626B1 (en) * 2020-08-27 2021-07-21 株式会社都ローラー工業 Inactivation method, inactivation device
CN114917267A (en) * 2022-04-25 2022-08-19 杭州西子卫生消毒药械有限公司 Iodine-containing disinfectant for skin and preparation method thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102617225A (en) * 2012-03-12 2012-08-01 河北科技大学 Agricultural inorganic sterilization composition and preparation method of agricultural inorganic sterilization composition
US20210387121A1 (en) * 2018-11-22 2021-12-16 Nikki-Universal Co., Ltd. Filtering material for air filters and method for manufacturing filtering material for air filters
CN111632192B (en) * 2020-06-19 2021-09-24 浙江大学 Iodine-carrying titanium alloy implant with antibacterial, osteogenic differentiation promoting and mineralization functions and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01290608A (en) * 1988-05-18 1989-11-22 Sunstar Inc Germicidal composition
JPH02110A (en) * 1987-10-02 1990-01-05 Sanyo Chem Ind Ltd Solid iodophor preparation
JP2005065965A (en) * 2003-08-22 2005-03-17 Kao Corp Deodorant composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02110A (en) * 1987-10-02 1990-01-05 Sanyo Chem Ind Ltd Solid iodophor preparation
JPH01290608A (en) * 1988-05-18 1989-11-22 Sunstar Inc Germicidal composition
JP2005065965A (en) * 2003-08-22 2005-03-17 Kao Corp Deodorant composition

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2366554A2 (en) 2010-03-16 2011-09-21 Ricoh Company, Ltd. Thermosensitive recording medium
US8709974B2 (en) 2010-03-16 2014-04-29 Ricoh Company, Ltd. Thermosensitive recording medium
JP6904626B1 (en) * 2020-08-27 2021-07-21 株式会社都ローラー工業 Inactivation method, inactivation device
JP2022039920A (en) * 2020-08-27 2022-03-10 株式会社都ローラー工業 Inactivation method, inactivation device
CN114917267A (en) * 2022-04-25 2022-08-19 杭州西子卫生消毒药械有限公司 Iodine-containing disinfectant for skin and preparation method thereof
CN114917267B (en) * 2022-04-25 2023-04-11 杭州西子卫生消毒药械有限公司 Iodine-containing disinfectant for skin and preparation method thereof

Also Published As

Publication number Publication date
CN101175405A (en) 2008-05-07
TW200640369A (en) 2006-12-01
CN101175405B (en) 2012-08-15
TWI365042B (en) 2012-06-01
JPWO2006123784A1 (en) 2008-12-25

Similar Documents

Publication Publication Date Title
EP2440702B1 (en) Antimicrobial textiles comprising peroxide
US7306777B2 (en) Antimicrobial composition
JP4807821B2 (en) Antibacterial composition and method for producing and using the same
WO2006123784A1 (en) Anti-bacterial composition and anti-bacterial material
CA1251034A (en) Chemically-active composition containing divalent iron ions
US20040245496A1 (en) Cleaning agent, antibacterial material, environment clarifying material, functional adsorbent
CA2959032A1 (en) Antimicrobial composition comprising an n-halamine and a halogen stabilizing compound
US20090218266A1 (en) Water treatment and methods of use
US20050129742A1 (en) Antimicrobial article with diffusion control layer
JP3956973B2 (en) Deodorant with excellent water resistance
CN105829486A (en) Aldehyde-gas-adsorbing liquid and gas-adsorbing processed product using same
AU2008343510A1 (en) Antimicrobial cellulose sponge and method of making
JP5854590B2 (en) Antibacterial / deodorant treatment agent and antibacterial / deodorant treatment article
JP3903167B2 (en) Active oxygen generating material
US20060024196A1 (en) Antimicrobial and deodorizing product
CN1237223C (en) Textile containing photocatalytic bacterialcide and its preparation method
JP2005350358A (en) Antibacterial sheet-formed material
IL301166A (en) Engineered multifunctional particles and thin durable coatings comprising crosslinked silane polymers containing urea
JPH07316009A (en) Antibacterial, antiviral and antifungal agent and its complex
US20100291818A1 (en) Coating composition and construction structure finish member having coating layer
RU2494622C2 (en) Biocidal composition
US20230149454A1 (en) Antiseptic applications of metal nanoparticle agglomerates
WO2001037670A2 (en) Antimicrobial hook and loop fastener
JPH09104852A (en) Paste, envelope, stamp and revenue stamp, and method for applying the paste
KR101659755B1 (en) Oxygen Reaction Catalyst Composition and Method for Preparing the Same

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680017152.6

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007516353

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 1200702442

Country of ref document: VN

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06756404

Country of ref document: EP

Kind code of ref document: A1